| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 6.82e-09 | 38 | 138 | 7 | GO:0000146 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1G MYH1 MYH2 MYH6 MYH11 DDX59 ATP7A KIF27 MYO9A DHX38 CHD8 MORC2 HSP90AA5P DHX9 HELB MSH6 MYO3A SMC1B HSP90AA1 HSP90AB1 | 8.63e-09 | 614 | 138 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | coumarin 7-hydroxylase activity | 3.23e-07 | 3 | 138 | 3 | GO:0008389 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.64e-06 | 118 | 138 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | NUSAP1 MYO1G MYH1 MYH2 MYH6 MYH11 KIF27 MYO9A IFT81 SPTB TOM1 TRIOBP DAXX MYO3A PTPRC SVIL SYNE2 DNM3 RACGAP1 MAP4K4 GOLGA2 HSP90AA1 HSP90AB1 | 1.82e-06 | 1099 | 138 | 23 | GO:0008092 |
| GeneOntologyMolecularFunction | actin filament binding | 4.11e-06 | 227 | 138 | 10 | GO:0051015 | |
| GeneOntologyMolecularFunction | CTP binding | 4.74e-05 | 2 | 138 | 2 | GO:0002135 | |
| GeneOntologyMolecularFunction | calcium,diacylglycerol-dependent serine/threonine kinase activity | 4.74e-05 | 2 | 138 | 2 | GO:0004698 | |
| GeneOntologyMolecularFunction | histone H3T6 kinase activity | 4.74e-05 | 2 | 138 | 2 | GO:0035403 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX59 ATP7A KIF27 DHX38 CHD8 MORC2 HSP90AA5P DHX9 HELB SMC1B HSP90AA1 HSP90AB1 | 5.74e-05 | 441 | 138 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 8.62e-05 | 34 | 138 | 4 | GO:0008395 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX59 ATP7A KIF27 DHX38 CHD8 MORC2 HSP90AA5P DHX9 HELB TSR1 GNL2 DNM3 RASEF SMC1B HSP90AA1 HSP90AB1 | 9.20e-05 | 775 | 138 | 16 | GO:0017111 |
| GeneOntologyMolecularFunction | aromatase activity | 9.68e-05 | 35 | 138 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | ZSWIM8 PDZK1P1 ATG14 DAXX ICE1 DTX3L NUPR1 DDB1 STRIP1 DHX9 NCOR1 PTPN11 KMT2D BNIP1 SYNE2 RACGAP1 PRKCB N4BP2L2 POLD3 MED12 | 1.41e-04 | 1160 | 138 | 20 | GO:0030674 |
| GeneOntologyMolecularFunction | sulfonylurea receptor binding | 1.42e-04 | 3 | 138 | 2 | GO:0017098 | |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 1.69e-04 | 16 | 138 | 3 | GO:0004697 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DDX59 ATP7A KIF27 DHX38 CHD8 MORC2 HSP90AA5P DHX9 HELB TSR1 GNL2 DNM3 RASEF SMC1B HSP90AA1 HSP90AB1 | 2.28e-04 | 839 | 138 | 16 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DDX59 ATP7A KIF27 DHX38 CHD8 MORC2 HSP90AA5P DHX9 HELB TSR1 GNL2 DNM3 RASEF SMC1B HSP90AA1 HSP90AB1 | 2.31e-04 | 840 | 138 | 16 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DDX59 ATP7A KIF27 DHX38 CHD8 MORC2 HSP90AA5P DHX9 HELB TSR1 GNL2 DNM3 RASEF SMC1B HSP90AA1 HSP90AB1 | 2.31e-04 | 840 | 138 | 16 | GO:0016818 |
| GeneOntologyMolecularFunction | UTP binding | 2.82e-04 | 4 | 138 | 2 | GO:0002134 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 3.64e-04 | 49 | 138 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | ZSWIM8 ITSN1 PDZK1P1 ATG14 DAXX ICE1 DTX3L NUPR1 DDB1 STRIP1 DHX9 NCOR1 PTPN11 KMT2D BNIP1 SYNE2 RACGAP1 PRKCB N4BP2L2 POLD3 MED12 | 4.10e-04 | 1356 | 138 | 21 | GO:0060090 |
| GeneOntologyMolecularFunction | pyrimidine ribonucleotide binding | 4.68e-04 | 5 | 138 | 2 | GO:0032557 | |
| GeneOntologyMolecularFunction | dATP binding | 4.68e-04 | 5 | 138 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | actin binding | MYO1G MYH1 MYH2 MYH6 MYH11 MYO9A SPTB TRIOBP MYO3A SVIL SYNE2 | 5.04e-04 | 479 | 138 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 5.88e-04 | 24 | 138 | 3 | GO:0008392 | |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 6.98e-04 | 6 | 138 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | 3'-5' RNA helicase activity | 6.98e-04 | 6 | 138 | 2 | GO:0034458 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 8.37e-04 | 27 | 138 | 3 | GO:0008391 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 9.73e-04 | 7 | 138 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.08e-03 | 229 | 138 | 7 | GO:0140993 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | CDC42BPA ADCK1 MINK1 AURKC MYO3A GRK3 PRKCA PRKCB PRKCG MAP4K4 | 1.09e-03 | 446 | 138 | 10 | GO:0004674 |
| GeneOntologyMolecularFunction | TPR domain binding | 1.29e-03 | 8 | 138 | 2 | GO:0030911 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 1.64e-03 | 73 | 138 | 4 | GO:0044183 | |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 1.65e-03 | 9 | 138 | 2 | GO:0032552 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | NSUN4 DDX59 DHX38 CHD8 ELAC2 DHX9 HELB MSH6 TARS3 N4BP2 TRMT13 POLD3 | 1.75e-03 | 645 | 138 | 12 | GO:0140640 |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine kinase activity | 2.06e-03 | 10 | 138 | 2 | GO:0009931 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 2.06e-03 | 10 | 138 | 2 | GO:0030235 | |
| GeneOntologyMolecularFunction | histone binding | 2.48e-03 | 265 | 138 | 7 | GO:0042393 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide binding | 2.50e-03 | 11 | 138 | 2 | GO:0019103 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 2.65e-03 | 40 | 138 | 3 | GO:0140662 | |
| GeneOntologyMolecularFunction | histone H3 kinase activity | 2.99e-03 | 12 | 138 | 2 | GO:0140996 | |
| GeneOntologyMolecularFunction | protein kinase activity | FLT1 CDC42BPA ADCK1 MINK1 AURKC MYO3A GRK3 PRKCA PRKCB PRKCG MAP4K4 | 3.03e-03 | 600 | 138 | 11 | GO:0004672 |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 3.48e-03 | 44 | 138 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 3.52e-03 | 13 | 138 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 3.71e-03 | 45 | 138 | 3 | GO:0043495 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | FLT1 CDC42BPA ADCK1 MINK1 AURKC MYO3A GRK3 N4BP2 PRKCA PRKCB PRKCG MAP4K4 | 3.78e-03 | 709 | 138 | 12 | GO:0016773 |
| GeneOntologyMolecularFunction | protein serine kinase activity | 3.79e-03 | 363 | 138 | 8 | GO:0106310 | |
| GeneOntologyMolecularFunction | D1 dopamine receptor binding | 4.09e-03 | 14 | 138 | 2 | GO:0031748 | |
| GeneOntologyBiologicalProcess | organelle assembly | ATXN2L NSUN4 MYH6 SLC9A8 MYH11 PPAN CEP85 CHMP6 KIF27 NOP53 IFT81 TOM1 DYNC2I1 ATG14 NUPR1 DDB1 CHMP7 AURKC NCOR1 CFAP20 SYNE2 RACGAP1 MRTO4 CEP152 GOLGA2 JHY | 3.28e-08 | 1138 | 138 | 26 | GO:0070925 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | ATXN2L NSUN4 MYH6 MYH11 PPAN CEP85 CHMP6 NOP53 DDB1 CHMP7 AURKC NCOR1 RACGAP1 MRTO4 CEP152 GOLGA2 | 1.24e-07 | 475 | 138 | 16 | GO:0140694 |
| GeneOntologyBiologicalProcess | chromosome organization | NUSAP1 CHMP6 CHD8 MORC2 DHX9 HELB ITGB3BP CHMP7 AURKC MSH6 SYCP2 ASCC2 RACGAP1 SLX4 GOLGA2 SMC1B HSP90AA1 HSP90AB1 | 7.73e-07 | 686 | 138 | 18 | GO:0051276 |
| GeneOntologyBiologicalProcess | cell cycle process | NUSAP1 CEP85 CHMP6 NOP53 SPART DAXX DTX3L MORC2 DDB1 ITGB3BP CHMP7 AURKC NCOR1 MSH6 SYCP2 PTPN11 PTPRC USP51 SVIL RACGAP1 PRKCA PRKCB CEP152 SLX4 GOLGA2 SMC1B | 3.04e-06 | 1441 | 138 | 26 | GO:0022402 |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 3.40e-05 | 10 | 138 | 3 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 3.40e-05 | 10 | 138 | 3 | GO:0009804 | |
| GeneOntologyBiologicalProcess | organelle fusion | 4.28e-05 | 190 | 138 | 8 | GO:0048284 | |
| GeneOntologyBiologicalProcess | organelle membrane fusion | 5.28e-05 | 144 | 138 | 7 | GO:0090174 | |
| GeneOntologyBiologicalProcess | chromosome segregation | NUSAP1 CEP85 CHMP6 MORC2 DDB1 ITGB3BP CHMP7 AURKC NCOR1 SYCP2 RACGAP1 GOLGA2 | 7.00e-05 | 465 | 138 | 12 | GO:0007059 |
| GeneOntologyBiologicalProcess | cytokinesis | 7.06e-05 | 204 | 138 | 8 | GO:0000910 | |
| GeneOntologyBiologicalProcess | spindle assembly | 7.75e-05 | 153 | 138 | 7 | GO:0051225 | |
| GeneOntologyBiologicalProcess | cellular response to cadmium ion | 1.93e-04 | 43 | 138 | 4 | GO:0071276 | |
| GeneOntologyCellularComponent | myosin complex | 1.61e-07 | 59 | 144 | 7 | GO:0016459 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYO1G MYH1 MYH2 MYH6 FLT1 MYH11 CDC42BPA ACACA MYO9A ITSN1 SPTB TRIOBP DHX9 MYO3A PTPN11 SVIL PRKCB | 4.89e-07 | 576 | 144 | 17 | GO:0015629 |
| GeneOntologyCellularComponent | muscle myosin complex | 3.69e-06 | 16 | 144 | 4 | GO:0005859 | |
| GeneOntologyCellularComponent | microtubule | NUSAP1 CYP2A6 CYP2A7 CYP2A13 CHMP6 KIF27 RIBC1 DAXX CHMP7 AURKC CFAP20 SVIL DNM3 RACGAP1 GOLGA2 | 4.28e-06 | 533 | 144 | 15 | GO:0005874 |
| GeneOntologyCellularComponent | supramolecular fiber | NUSAP1 MYH1 MYH2 CYP2A6 CYP2A7 MYH6 CYP2A13 MYH11 CHMP6 KIF27 MYO9A RIBC1 DAXX CHMP7 AURKC MYO3A GRK3 CFAP20 SVIL SYNE2 DNM3 RACGAP1 GOLGA2 | 5.79e-06 | 1179 | 144 | 23 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | NUSAP1 MYH1 MYH2 CYP2A6 CYP2A7 MYH6 CYP2A13 MYH11 CHMP6 KIF27 MYO9A RIBC1 DAXX CHMP7 AURKC MYO3A GRK3 CFAP20 SVIL SYNE2 DNM3 RACGAP1 GOLGA2 | 6.47e-06 | 1187 | 144 | 23 | GO:0099081 |
| GeneOntologyCellularComponent | myosin filament | 2.44e-05 | 25 | 144 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 3.89e-05 | 28 | 144 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | calyx of Held | 1.07e-04 | 36 | 144 | 4 | GO:0044305 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | NUSAP1 CYP2A6 CYP2A7 CYP2A13 CHMP6 KIF27 MYO9A RIBC1 DAXX CHMP7 AURKC MYO3A CFAP20 SVIL DNM3 RACGAP1 GOLGA2 | 1.56e-04 | 899 | 144 | 17 | GO:0099513 |
| GeneOntologyCellularComponent | chromosomal region | CHMP6 TRIOBP DAXX DDB1 THOC5 ITGB3BP CHMP7 AURKC SYCP2 SLX4 SMC1B | 1.65e-04 | 421 | 144 | 11 | GO:0098687 |
| GeneOntologyCellularComponent | dendrite terminus | 3.35e-04 | 20 | 144 | 3 | GO:0044292 | |
| GeneOntologyCellularComponent | presynaptic cytosol | 3.60e-04 | 49 | 144 | 4 | GO:0099523 | |
| GeneOntologyCellularComponent | ooplasm | 6.94e-04 | 6 | 144 | 2 | GO:1990917 | |
| GeneOntologyCellularComponent | midbody | 8.91e-04 | 222 | 144 | 7 | GO:0030496 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 9.14e-04 | 223 | 144 | 7 | GO:0098862 | |
| GeneOntologyCellularComponent | pericentriolar material | 9.24e-04 | 28 | 144 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | multivesicular body membrane | 1.13e-03 | 30 | 144 | 3 | GO:0032585 | |
| GeneOntologyCellularComponent | cytosolic region | 1.39e-03 | 70 | 144 | 4 | GO:0099522 | |
| GeneOntologyCellularComponent | spectrin | 1.64e-03 | 9 | 144 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | cytoplasmic microtubule | 2.30e-03 | 133 | 144 | 5 | GO:0005881 | |
| Domain | NPIP | NPIPB15 NPIPB9 NPIPA1 NPIPA7 NPIPB8 NPIPB6 NPIPA5 NPIPA3 NPIPA2 | 1.54e-16 | 14 | 145 | 9 | IPR009443 |
| Domain | Myosin_head_motor_dom | 1.52e-08 | 38 | 145 | 7 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.52e-08 | 38 | 145 | 7 | PS51456 | |
| Domain | Myosin_head | 1.52e-08 | 38 | 145 | 7 | PF00063 | |
| Domain | MYSc | 1.52e-08 | 38 | 145 | 7 | SM00242 | |
| Domain | Protein_kinase_C_a/b/g | 4.58e-07 | 3 | 145 | 3 | IPR014375 | |
| Domain | P-loop_NTPase | MYO1G MYH1 MYH2 MYH6 MYH11 DDX59 SAMD9 KIF27 MYO9A DHX38 CHD8 DHX9 HELB MSH6 MYO3A SAMD9L N4BP2 GNL2 DNM3 N4BP2L2 RASEF SMC1B | 6.42e-07 | 848 | 145 | 22 | IPR027417 |
| Domain | Cyt_P450_E_grp-I_CYP2A-like | 1.82e-06 | 4 | 145 | 3 | IPR008067 | |
| Domain | Myosin_N | 4.45e-06 | 15 | 145 | 4 | PF02736 | |
| Domain | Myosin_N | 4.45e-06 | 15 | 145 | 4 | IPR004009 | |
| Domain | Myosin_tail_1 | 9.80e-06 | 18 | 145 | 4 | PF01576 | |
| Domain | Myosin_tail | 9.80e-06 | 18 | 145 | 4 | IPR002928 | |
| Domain | ZF_DAG_PE_1 | 1.02e-05 | 64 | 145 | 6 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.02e-05 | 64 | 145 | 6 | PS50081 | |
| Domain | C1 | 1.12e-05 | 65 | 145 | 6 | SM00109 | |
| Domain | PE/DAG-bd | 1.22e-05 | 66 | 145 | 6 | IPR002219 | |
| Domain | Myosin-like_IQ_dom | 1.23e-05 | 19 | 145 | 4 | IPR027401 | |
| Domain | - | 1.23e-05 | 19 | 145 | 4 | 4.10.270.10 | |
| Domain | IQ | 1.87e-05 | 71 | 145 | 6 | PF00612 | |
| Domain | IQ | 3.97e-05 | 81 | 145 | 6 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 7.19e-05 | 90 | 145 | 6 | IPR000048 | |
| Domain | AGC-kinase_C | 7.31e-05 | 56 | 145 | 5 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 7.31e-05 | 56 | 145 | 5 | PS51285 | |
| Domain | S_TK_X | 7.31e-05 | 56 | 145 | 5 | SM00133 | |
| Domain | C1_1 | 7.96e-05 | 57 | 145 | 5 | PF00130 | |
| Domain | IQ | 8.64e-05 | 93 | 145 | 6 | PS50096 | |
| Domain | CNH | 1.57e-04 | 14 | 145 | 3 | SM00036 | |
| Domain | Heat_shock_protein_90_CS | 1.79e-04 | 3 | 145 | 2 | IPR019805 | |
| Domain | Pkinase_C | 1.89e-04 | 37 | 145 | 4 | IPR017892 | |
| Domain | CNH | 1.95e-04 | 15 | 145 | 3 | PF00780 | |
| Domain | CNH | 1.95e-04 | 15 | 145 | 3 | PS50219 | |
| Domain | CNH_dom | 1.95e-04 | 15 | 145 | 3 | IPR001180 | |
| Domain | Post-SET_dom | 2.38e-04 | 16 | 145 | 3 | IPR003616 | |
| Domain | PostSET | 2.38e-04 | 16 | 145 | 3 | SM00508 | |
| Domain | POST_SET | 2.38e-04 | 16 | 145 | 3 | PS50868 | |
| Domain | Pkinase_C | 3.10e-04 | 42 | 145 | 4 | PF00433 | |
| Domain | HATPase_c | 3.43e-04 | 18 | 145 | 3 | SM00387 | |
| Domain | Hsp90_fam | 3.56e-04 | 4 | 145 | 2 | IPR001404 | |
| Domain | Hsp90_N | 3.56e-04 | 4 | 145 | 2 | IPR020575 | |
| Domain | HSP90 | 3.56e-04 | 4 | 145 | 2 | PF00183 | |
| Domain | HSP90 | 3.56e-04 | 4 | 145 | 2 | PS00298 | |
| Domain | HATPase_c | 4.05e-04 | 19 | 145 | 3 | PF02518 | |
| Domain | Cyt_P450_E_grp-I | 4.06e-04 | 45 | 145 | 4 | IPR002401 | |
| Domain | - | 4.74e-04 | 20 | 145 | 3 | 3.30.565.10 | |
| Domain | PWWP | 4.74e-04 | 20 | 145 | 3 | SM00293 | |
| Domain | DAG/PE-bd | 5.50e-04 | 21 | 145 | 3 | IPR020454 | |
| Domain | HATPase_C | 5.50e-04 | 21 | 145 | 3 | IPR003594 | |
| Domain | AWS | 5.89e-04 | 5 | 145 | 2 | SM00570 | |
| Domain | AWS | 5.89e-04 | 5 | 145 | 2 | PS51215 | |
| Domain | AWS_dom | 5.89e-04 | 5 | 145 | 2 | IPR006560 | |
| Domain | PWWP | 7.24e-04 | 23 | 145 | 3 | PF00855 | |
| Domain | PWWP_dom | 7.24e-04 | 23 | 145 | 3 | IPR000313 | |
| Domain | Cyt_P450_CS | 7.60e-04 | 53 | 145 | 4 | IPR017972 | |
| Domain | Protein_kinase_ATP_BS | FLT1 CDC42BPA MINK1 AURKC MYO3A GRK3 PRKCA PRKCB PRKCG MAP4K4 | 7.66e-04 | 379 | 145 | 10 | IPR017441 |
| Domain | PWWP | 8.23e-04 | 24 | 145 | 3 | PS50812 | |
| Domain | tRNA-bd_arm | 8.23e-04 | 24 | 145 | 3 | IPR010978 | |
| Domain | PROTEIN_KINASE_ATP | FLT1 CDC42BPA ADCK1 MINK1 AURKC MYO3A GRK3 PRKCA PRKCB PRKCG MAP4K4 | 9.25e-04 | 459 | 145 | 11 | PS00107 |
| Domain | CYTOCHROME_P450 | 1.00e-03 | 57 | 145 | 4 | PS00086 | |
| Domain | p450 | 1.07e-03 | 58 | 145 | 4 | PF00067 | |
| Domain | Kinase-like_dom | FLT1 CDC42BPA ADCK1 MINK1 AURKC MYO3A GRK3 DNM3 PRKCA PRKCB PRKCG MAP4K4 | 1.08e-03 | 542 | 145 | 12 | IPR011009 |
| Domain | Cyt_P450 | 1.21e-03 | 60 | 145 | 4 | IPR001128 | |
| Domain | Prot_kinase_dom | FLT1 CDC42BPA ADCK1 MINK1 AURKC MYO3A GRK3 PRKCA PRKCB PRKCG MAP4K4 | 1.54e-03 | 489 | 145 | 11 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | FLT1 CDC42BPA ADCK1 MINK1 AURKC MYO3A GRK3 PRKCA PRKCB PRKCG MAP4K4 | 1.64e-03 | 493 | 145 | 11 | PS50011 |
| Domain | Ser/Thr_kinase_AS | 1.92e-03 | 357 | 145 | 9 | IPR008271 | |
| Domain | S_TKc | 1.99e-03 | 359 | 145 | 9 | SM00220 | |
| Domain | - | DDX59 SAMD9 DHX38 CHD8 DHX9 HELB MSH6 SAMD9L N4BP2 GNL2 DNM3 N4BP2L2 RASEF SMC1B | 2.03e-03 | 746 | 145 | 14 | 3.40.50.300 |
| Domain | PROTEIN_KINASE_ST | 2.10e-03 | 362 | 145 | 9 | PS00108 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.50e-03 | 35 | 145 | 3 | IPR002464 | |
| Domain | Anoctamin | 2.59e-03 | 10 | 145 | 2 | PF04547 | |
| Domain | Anoctamin | 2.59e-03 | 10 | 145 | 2 | IPR007632 | |
| Domain | CUE | 2.59e-03 | 10 | 145 | 2 | IPR003892 | |
| Domain | CUE | 2.59e-03 | 10 | 145 | 2 | PS51140 | |
| Domain | Pkinase | 2.96e-03 | 381 | 145 | 9 | PF00069 | |
| Domain | DEAH_ATP_HELICASE | 3.17e-03 | 38 | 145 | 3 | PS00690 | |
| Domain | Snf7_fam | 3.75e-03 | 12 | 145 | 2 | IPR005024 | |
| Domain | Snf7 | 3.75e-03 | 12 | 145 | 2 | PF03357 | |
| Domain | SET | 3.94e-03 | 41 | 145 | 3 | PF00856 | |
| Domain | SET | 5.45e-03 | 46 | 145 | 3 | SM00317 | |
| Domain | SET_dom | 6.88e-03 | 50 | 145 | 3 | IPR001214 | |
| Domain | SET | 6.88e-03 | 50 | 145 | 3 | PS50280 | |
| Domain | DUF1605 | 7.54e-03 | 17 | 145 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 7.54e-03 | 17 | 145 | 2 | PF07717 | |
| Pathway | PID_VEGFR1_PATHWAY | 8.16e-07 | 26 | 97 | 5 | M226 | |
| Pathway | REACTOME_DISINHIBITION_OF_SNARE_FORMATION | 3.13e-06 | 5 | 97 | 3 | M26920 | |
| Pathway | PID_VEGFR1_2_PATHWAY | 7.67e-06 | 69 | 97 | 6 | M237 | |
| Pathway | REACTOME_XENOBIOTICS | 1.69e-05 | 23 | 97 | 4 | M5372 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US27_TO_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 1.72e-05 | 8 | 97 | 3 | M47555 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY | 1.72e-05 | 8 | 97 | 3 | M47479 | |
| Pathway | KEGG_TIGHT_JUNCTION | 3.43e-05 | 132 | 97 | 7 | M11355 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY | 3.66e-05 | 10 | 97 | 3 | M47644 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 5.01e-05 | 11 | 97 | 3 | M27130 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY | 5.01e-05 | 11 | 97 | 3 | M47637 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY | 6.64e-05 | 12 | 97 | 3 | M47597 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY | 6.64e-05 | 12 | 97 | 3 | M47649 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY | 6.64e-05 | 12 | 97 | 3 | M47628 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 6.64e-05 | 12 | 97 | 3 | MM14847 | |
| Pathway | REACTOME_CELL_CYCLE | CHMP6 NSD2 DAXX ITGB3BP CHMP7 SYCP2 SYNE2 PRKCA PRKCB CEP152 POLD3 GOLGA2 SMC1B HSP90AA1 HSP90AB1 | 7.46e-05 | 694 | 97 | 15 | M543 |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 7.69e-05 | 64 | 97 | 5 | M7923 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 8.59e-05 | 13 | 97 | 3 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY | 1.09e-04 | 14 | 97 | 3 | M47383 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY | 1.09e-04 | 14 | 97 | 3 | M47384 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY | 1.35e-04 | 15 | 97 | 3 | M47382 | |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4 | 1.35e-04 | 15 | 97 | 3 | M27413 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 2.00e-04 | 17 | 97 | 3 | M5488 | |
| Pathway | PID_THROMBIN_PAR1_PATHWAY | 2.12e-04 | 43 | 97 | 4 | M238 | |
| Pathway | REACTOME_FATTY_ACIDS | 2.39e-04 | 18 | 97 | 3 | MM14841 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 2.75e-04 | 46 | 97 | 4 | M19118 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 2.75e-04 | 46 | 97 | 4 | MM1428 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY | 2.83e-04 | 19 | 97 | 3 | M47596 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY | 3.84e-04 | 21 | 97 | 3 | M47638 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 4.11e-04 | 51 | 97 | 4 | M17726 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 4.11e-04 | 51 | 97 | 4 | MM14967 | |
| Pathway | WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING | 4.26e-04 | 92 | 97 | 5 | M39441 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 4.33e-04 | 261 | 97 | 8 | MM15676 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 4.43e-04 | 52 | 97 | 4 | M2404 | |
| Pathway | BIOCARTA_ION_PATHWAY | 4.62e-04 | 5 | 97 | 2 | MM1574 | |
| Pathway | BIOCARTA_PLCD_PATHWAY | 4.62e-04 | 5 | 97 | 2 | MM1587 | |
| Pathway | BIOCARTA_ION_PATHWAY | 4.62e-04 | 5 | 97 | 2 | M22059 | |
| Pathway | BIOCARTA_PLCD_PATHWAY | 4.62e-04 | 5 | 97 | 2 | M22080 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS | 4.62e-04 | 5 | 97 | 2 | M47808 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 5.18e-04 | 96 | 97 | 5 | M16121 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | ZSWIM8 MYH11 ITSN1 SPTB PTPN11 PTPRC SEMA6D DNM3 PRKCA HSP90AA1 CNTN1 HSP90AB1 | 5.69e-04 | 575 | 97 | 12 | M29853 |
| Pathway | PID_TXA2PATHWAY | 5.88e-04 | 56 | 97 | 4 | M99 | |
| Pathway | REACTOME_XENOBIOTICS | 6.51e-04 | 25 | 97 | 3 | MM14846 | |
| Pathway | REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN | 6.90e-04 | 6 | 97 | 2 | M27430 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY | 7.32e-04 | 26 | 97 | 3 | M47557 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 7.47e-04 | 104 | 97 | 5 | M738 | |
| Pathway | BIOCARTA_VEGF_PATHWAY | 8.19e-04 | 27 | 97 | 3 | M12975 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 8.66e-04 | 62 | 97 | 4 | M39653 | |
| Pathway | PID_IL8_CXCR1_PATHWAY | 9.13e-04 | 28 | 97 | 3 | M252 | |
| Pathway | BIOCARTA_ERBB4_PATHWAY | 9.62e-04 | 7 | 97 | 2 | MM1563 | |
| Pathway | BIOCARTA_PKC_PATHWAY | 9.62e-04 | 7 | 97 | 2 | MM1572 | |
| Pathway | BIOCARTA_ERBB4_PATHWAY | 9.62e-04 | 7 | 97 | 2 | M22043 | |
| Pathway | BIOCARTA_PKC_PATHWAY | 9.62e-04 | 7 | 97 | 2 | M22057 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 9.76e-04 | 64 | 97 | 4 | M5650 | |
| Pathway | PID_TCR_PATHWAY | 9.76e-04 | 64 | 97 | 4 | M34 | |
| Pathway | KEGG_RETINOL_METABOLISM | 9.76e-04 | 64 | 97 | 4 | M9488 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 1.05e-03 | 299 | 97 | 8 | M41727 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 1.23e-03 | 31 | 97 | 3 | M47554 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.23e-03 | 31 | 97 | 3 | M7223 | |
| Pathway | REACTOME_HSF1_ACTIVATION | 1.28e-03 | 8 | 97 | 2 | MM14950 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 1.36e-03 | 32 | 97 | 3 | M39567 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.36e-03 | 70 | 97 | 4 | M12294 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.52e-03 | 72 | 97 | 4 | M9257 | |
| Pathway | PID_IL8_CXCR2_PATHWAY | 1.62e-03 | 34 | 97 | 3 | M210 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 1.63e-03 | 9 | 97 | 2 | M22029 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 1.63e-03 | 9 | 97 | 2 | MM1551 | |
| Pathway | BIOCARTA_SRCRPTP_PATHWAY | 2.03e-03 | 10 | 97 | 2 | MM1341 | |
| Pathway | BIOCARTA_AGPCR_PATHWAY | 2.03e-03 | 10 | 97 | 2 | MM1352 | |
| Pubmed | NUSAP1 CEP85 CDC42BPA NSD2 NOP53 MINK1 DHX38 MCAM TRIOBP PFDN2 CCDC77 NSD3 NCOR1 MSH6 PTPN11 KMT2D PTPRC TSR1 SVIL SYNE2 GNL2 RELL1 CRYBG3 HSP90AA1 HSP90AB1 | 9.70e-12 | 1049 | 156 | 25 | 27880917 | |
| Pubmed | NUSAP1 NSUN4 PPAN CDC42BPA NSD2 NOP53 MINK1 DHX38 TOM1 TRIOBP DAXX CHD8 ICE1 MORC2 INTS8 STRIP1 STT3B NSD3 HMG20A MSH6 IFRD1 ZNF24 TSR1 CFAP20 GNL2 ASCC2 ZBTB11 MED12 | 1.36e-10 | 1497 | 156 | 28 | 31527615 | |
| Pubmed | Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling. | 3.89e-10 | 4 | 156 | 4 | 18055785 | |
| Pubmed | 2.13e-09 | 13 | 156 | 5 | 8948582 | ||
| Pubmed | ITSN1 MINK1 TRIOBP CHD8 DDB1 STRIP1 NCOR1 N4BP2 SVIL SYNE2 DNM3 RACGAP1 PRKCA PRKCB ERC2 PRKCG MAP4K4 GOLGA2 HSP90AA1 CNTN1 HSP90AB1 | 2.50e-09 | 963 | 156 | 21 | 28671696 | |
| Pubmed | MYH1 MYH2 CYP2A6 MYH6 CYP2A13 MYH11 PPAN CCDC185 NSD2 IFT81 ITSN1 CAGE1 CCDC77 STT3B NCOR1 BNIP1 N4BP2 CSPG4 SYNE2 ANKRD30A ERC2 ZBTB11 HSP90AA1 UTP14C HSP90AB1 | 6.92e-09 | 1442 | 156 | 25 | 35575683 | |
| Pubmed | ATP7A CDC42BPA IFT81 ITSN1 MINK1 TRIOBP SPART CCDC77 TIMMDC1 DDB1 ELAC2 THOC5 STT3B DHX9 CHMP7 BNIP1 TSR1 N4BP2 SYNE2 GNL2 ASCC2 MRTO4 RELL1 CRYBG3 MAP4K4 | 1.27e-08 | 1487 | 156 | 25 | 33957083 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATXN2L PPAN ACACA ITSN1 MINK1 DAXX MORC2 STRIP1 DHX9 NCOR1 MSH6 MYO3A KMT2D PTPRC SVIL KLHDC4 MAP4K4 HSP90AB1 | 1.42e-08 | 774 | 156 | 18 | 15302935 |
| Pubmed | MYH11 CDC42BPA MYO9A CCDC186 ITSN1 DAXX CHD8 NSD3 USF3 N4BP2 MAP4K4 GOLGA2 HSP90AA1 HSP90AB1 | 4.69e-08 | 486 | 156 | 14 | 20936779 | |
| Pubmed | SLC9A8 MYH11 DHX38 ATG14 MORC2 THOC5 USF3 SAMD9L N4BP2 CEP152 MED12 SLX4 TRAPPC9 UTP14C | 5.60e-08 | 493 | 156 | 14 | 15368895 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ACACA IFT81 ITSN1 RIBC1 DYNC2I1 PFDN2 CCDC77 DDB1 NCOR1 TSR1 N4BP2 SVIL PRKCA RASEF CEP152 MAP4K4 HSP90AA1 HSP90AB1 | 6.15e-08 | 853 | 156 | 18 | 28718761 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NUSAP1 ATXN2L NSUN4 PPAN NSD2 NOP53 ATG14 DDB1 DHX9 MSH6 TSR1 GNL2 RACGAP1 ERC2 MRTO4 ZBTB11 MED12 | 6.29e-08 | 759 | 156 | 17 | 35915203 |
| Pubmed | Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition. | 8.85e-08 | 3 | 156 | 3 | 31645370 | |
| Pubmed | Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals. | 8.85e-08 | 3 | 156 | 3 | 9814702 | |
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 8297477 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 8188299 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 8250953 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 2703500 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 22217847 | ||
| Pubmed | Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract. | 8.85e-08 | 3 | 156 | 3 | 22890016 | |
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 3346244 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 2733794 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 8484736 | ||
| Pubmed | Protein and molecular characterization of hippocampal protein kinase C in C57BL/6 and DBA/2 mice. | 8.85e-08 | 3 | 156 | 3 | 7760054 | |
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 22819675 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 3755548 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 1714454 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 1417950 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 24045421 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 32987105 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 2765478 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 2415518 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 19895572 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 19556521 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 27307229 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NSUN4 CDC42BPA NSD2 TRIOBP INTS8 DDB1 THOC5 STT3B NSD3 HMG20A DHX9 MSH6 TSR1 CFAP20 GNL2 DNM3 MAP4K4 MED12 HSP90AA1 HSP90AB1 | 9.32e-08 | 1082 | 156 | 20 | 38697112 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ATXN2L DDX59 PPAN ACACA DHX38 DAXX CHD8 DHX9 MSH6 GNL2 ASCC2 ZBTB11 SLX4 | 1.08e-07 | 440 | 156 | 13 | 34244565 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | NUSAP1 NSD2 DAXX CHD8 MORC2 DDB1 NSD3 HMG20A MSH6 ZNF24 TSR1 GNL2 RACGAP1 ZBTB11 SENP7 | 1.15e-07 | 608 | 156 | 15 | 36089195 |
| Pubmed | ATXN2L MYH6 MYH11 HTRA1 MYO9A TNC ITSN1 SPTB MINK1 TOM1 DDB1 STRIP1 DHX9 TARS3 SVIL PRKCA PRKCB ERC2 PRKCG TRAPPC9 HSP90AA1 CNTN1 HSP90AB1 | 1.16e-07 | 1431 | 156 | 23 | 37142655 | |
| Pubmed | Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. | 2.03e-07 | 92 | 156 | 7 | 10493829 | |
| Pubmed | Mitochondrial phosphoproteome revealed by an improved IMAC method and MS/MS/MS. | 2.22e-07 | 57 | 156 | 6 | 17208939 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NUSAP1 ATXN2L PPAN SAMD9 NOP53 DHX38 DDB1 THOC5 STT3B NSD3 DHX9 MSH6 TSR1 SVIL GNL2 ASCC2 RACGAP1 MRTO4 GOLGA2 HSP90AA1 HSP90AB1 | 2.32e-07 | 1257 | 156 | 21 | 36526897 |
| Pubmed | PPAN ACACA NOP53 DHX38 SPART DAXX DDB1 STT3B DHX9 MSH6 IFRD1 ZNF24 TSR1 WBP4 MRTO4 | 2.85e-07 | 653 | 156 | 15 | 33742100 | |
| Pubmed | ATXN2L ZSWIM8 ACACA NSD2 NOP53 DHX38 CHD8 DDB1 MSH6 TSR1 SYNE2 GNL2 MRTO4 ZBTB11 MED12 | 2.85e-07 | 653 | 156 | 15 | 22586326 | |
| Pubmed | ZSWIM8 CEP85 IFT81 ITSN1 SPTB TRIOBP DYNC2I1 PFDN2 INTS8 HMG20A ITGB3BP TARS3 DNM3 ERC2 N4BP2L2 ANKRD36 ZBTB11 MAP4K4 SLX4 HSP90AA1 HSP90AB1 | 3.33e-07 | 1285 | 156 | 21 | 35914814 | |
| Pubmed | Serine phosphorylation of syndecan-2 proteoglycan cytoplasmic domain. | 3.53e-07 | 4 | 156 | 3 | 9244383 | |
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 10490589 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 9694886 | ||
| Pubmed | Two steroid 15 alpha-hydroxylase genes and a homologous gene family in mice. | 3.53e-07 | 4 | 156 | 3 | 1970547 | |
| Pubmed | Characterization of a 7.5-kDa protein kinase C substrate (RC3 protein, neurogranin) from rat brain. | 3.53e-07 | 4 | 156 | 3 | 8080473 | |
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 10871288 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 8631738 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 7499337 | ||
| Pubmed | Regulation of ARNO nucleotide exchange by a PH domain electrostatic switch. | 3.53e-07 | 4 | 156 | 3 | 10531036 | |
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 9408084 | ||
| Pubmed | Protein kinase C phosphorylation of syntaxin 4 in thrombin-activated human platelets. | 3.53e-07 | 4 | 156 | 3 | 10856305 | |
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 15367584 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 7565685 | ||
| Pubmed | Physiological regulation of Munc18/nSec1 phosphorylation on serine-313. | 3.53e-07 | 4 | 156 | 3 | 12950453 | |
| Pubmed | Presynaptic Short-Term Plasticity Persists in the Absence of PKC Phosphorylation of Munc18-1. | 3.53e-07 | 4 | 156 | 3 | 34290081 | |
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 8662663 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 11063746 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L CDC42BPA ACACA MYO9A MINK1 NSD3 IFRD1 N4BP2 SVIL SYNE2 RACGAP1 PRKCG CEP152 CRYBG3 MAP4K4 SH3RF3 TRAPPC9 | 3.71e-07 | 861 | 156 | 17 | 36931259 |
| Pubmed | Distinct requirements for Gab1 in Met and EGF receptor signaling in vivo. | 3.76e-07 | 14 | 156 | 4 | 17881575 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ATXN2L ZSWIM8 CEP85 MYO9A ITSN1 DHX38 SPART DAXX NCOR1 N4BP2 ERC2 CRYBG3 SLX4 GOLGA2 | 4.72e-07 | 588 | 156 | 14 | 38580884 |
| Pubmed | ATXN2L PPAN CHD8 MORC2 STRIP1 CHMP7 NCOR1 MSH6 GMEB1 RACGAP1 PRKCA GOLGA2 HSP90AB1 | 4.94e-07 | 503 | 156 | 13 | 16964243 | |
| Pubmed | HTRA1 ITSN1 TOM1 MCAM SPART DDB1 HMG20A NCOR1 KMT2D PTPRC CSPG4 GMEB1 ASCC2 ZBTB11 | 5.02e-07 | 591 | 156 | 14 | 15231748 | |
| Pubmed | NUSAP1 NSD2 DHX38 CHD8 MORC2 DDB1 ELAC2 THOC5 NSD3 HMG20A DHX9 NCOR1 MSH6 PTPN11 TSR1 POLD3 MED12 HSP90AA1 | 7.69e-07 | 1014 | 156 | 18 | 32416067 | |
| Pubmed | ATXN2L ATP7A CDC42BPA MYO9A MINK1 SPART DDB1 STT3B DHX9 PTPN11 CRYBG3 MAP4K4 MED12 HSP90AA1 HSP90AB1 | 7.85e-07 | 708 | 156 | 15 | 39231216 | |
| Pubmed | ATXN2L PPAN CDC42BPA ACACA PFDN2 DDB1 ELAC2 THOC5 DHX9 NCOR1 TSR1 CFAP20 SVIL ASCC2 RACGAP1 POLD3 MED12 GOLGA2 HSP90AA1 HSP90AB1 | 8.70e-07 | 1247 | 156 | 20 | 27684187 | |
| Pubmed | 8.79e-07 | 5 | 156 | 3 | 7513693 | ||
| Pubmed | Role of two conserved cytoplasmic threonine residues (T410 and T412) in CD5 signaling. | 8.79e-07 | 5 | 156 | 3 | 11123317 | |
| Pubmed | Phosphorylation of vitronectin on Ser362 by protein kinase C attenuates its cleavage by plasmin. | 8.79e-07 | 5 | 156 | 3 | 9030777 | |
| Pubmed | 8.79e-07 | 5 | 156 | 3 | 12569090 | ||
| Pubmed | 8.79e-07 | 5 | 156 | 3 | 2590242 | ||
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 8.79e-07 | 5 | 156 | 3 | 30737693 | |
| Pubmed | 8.79e-07 | 5 | 156 | 3 | 30013171 | ||
| Pubmed | 8.79e-07 | 5 | 156 | 3 | 28228266 | ||
| Pubmed | Protein kinase C regulates the phosphorylation and cellular localization of occludin. | 8.79e-07 | 5 | 156 | 3 | 11502742 | |
| Pubmed | Regulation of the ErbB3 binding protein Ebp1 by protein kinase C. | 8.79e-07 | 5 | 156 | 3 | 11325528 | |
| Pubmed | Protein kinase C activity regulates the onset of anaphase I in mouse oocytes. | 8.79e-07 | 5 | 156 | 3 | 15229137 | |
| Pubmed | PKCβ phosphorylates PI3Kγ to activate it and release it from GPCR control. | 8.79e-07 | 5 | 156 | 3 | 23824069 | |
| Pubmed | Phosphorylation of Munc18 by protein kinase C regulates the kinetics of exocytosis. | 8.79e-07 | 5 | 156 | 3 | 12519779 | |
| Pubmed | 8.79e-07 | 5 | 156 | 3 | 20392936 | ||
| Pubmed | NUSAP1 DDX59 NSD2 IFT81 SPART CCDC77 MORC2 ELAC2 NSD3 PTPN11 TSR1 RACGAP1 CEP152 MED12 | 1.41e-06 | 645 | 156 | 14 | 25281560 | |
| Pubmed | Specific protein kinase C isoforms are required for rod photoreceptor differentiation. | 1.75e-06 | 6 | 156 | 3 | 22171059 | |
| Pubmed | 1.75e-06 | 6 | 156 | 3 | 7668294 | ||
| Pubmed | Evidence for direct protein kinase-C mediated modulation of N-methyl-D-aspartate receptor current. | 1.75e-06 | 6 | 156 | 3 | 11306676 | |
| Pubmed | 1.75e-06 | 6 | 156 | 3 | 8940188 | ||
| Pubmed | 1.75e-06 | 6 | 156 | 3 | 24863469 | ||
| Pubmed | 1.75e-06 | 6 | 156 | 3 | 10879655 | ||
| Pubmed | The use of fluorescent phorbol esters in studies of protein kinase C-membrane interactions. | 1.75e-06 | 6 | 156 | 3 | 12093536 | |
| Pubmed | An immunohistochemical study of protein kinase C distribution in fetal mouse vertebral column. | 1.75e-06 | 6 | 156 | 3 | 7985811 | |
| Pubmed | 1.75e-06 | 6 | 156 | 3 | 8587134 | ||
| Pubmed | PKCε Inhibits Neuronal Dendritic Spine Development through Dual Phosphorylation of Ephexin5. | 1.75e-06 | 6 | 156 | 3 | 30485813 | |
| Pubmed | Molecular genetics of the human cytochrome P450 monooxygenase superfamily. | 1.78e-06 | 20 | 156 | 4 | 9890157 | |
| Pubmed | NUSAP1 PPAN CEP85 CDC42BPA NOP53 CHD8 MORC2 DDB1 HMG20A NCOR1 ZNF24 KMT2D SVIL SYNE2 GNL2 GMEB1 RACGAP1 MRTO4 CEP152 SLX4 TRAPPC9 | 1.82e-06 | 1429 | 156 | 21 | 35140242 | |
| Pubmed | 2.68e-06 | 22 | 156 | 4 | 22902628 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | NUSAP1 ZSWIM8 CHMP6 CDC42BPA ACACA CHD8 NCOR1 MSH6 ZNF24 HSP90AA1 UTP14C | 2.76e-06 | 411 | 156 | 11 | 35182466 |
| Pubmed | Identification of substrates of SMURF1 ubiquitin ligase activity utilizing protein microarrays. | 2.77e-06 | 87 | 156 | 6 | 20804422 | |
| Interaction | AURKC interactions | 8.16e-10 | 43 | 148 | 8 | int:AURKC | |
| Interaction | NUP43 interactions | ACACA NSD2 NOP53 CHD8 PFDN2 ICE1 MORC2 NUPR1 DDB1 NSD3 HELB NCOR1 KMT2D SYNE2 GNL2 ZBTB11 MED12 SLX4 HSP90AB1 | 1.69e-07 | 625 | 148 | 19 | int:NUP43 |
| Interaction | SIRT6 interactions | ATXN2L DDX59 PPAN ACACA DHX38 DYNC2I1 DAXX CHD8 DDB1 RAX DHX9 MSH6 GNL2 ASCC2 N4BP2L2 POLD3 ZBTB11 MED12 SLX4 | 1.82e-07 | 628 | 148 | 19 | int:SIRT6 |
| Interaction | HABP4 interactions | 2.36e-07 | 156 | 148 | 10 | int:HABP4 | |
| Interaction | CYP2A7 interactions | 3.88e-07 | 3 | 148 | 3 | int:CYP2A7 | |
| Interaction | HDAC1 interactions | MYH1 MYH2 CDC42BPA ACACA NSD2 DAXX CHD8 PFDN2 NUPR1 DDB1 THOC5 HMG20A NCOR1 MSH6 IFRD1 KMT2D TSR1 SYNE2 ASCC2 CRYBG3 POLD3 ZBTB11 MED12 HSP90AA1 HSP90AB1 | 4.97e-07 | 1108 | 148 | 25 | int:HDAC1 |
| Interaction | SLX4 interactions | ACACA NOP53 DHX38 SPART DAXX CHD8 CCDC77 MORC2 DDB1 DHX9 NCOR1 MSH6 PTPN11 RACGAP1 SLX4 HSP90AA1 HSP90AB1 | 1.08e-06 | 572 | 148 | 17 | int:SLX4 |
| Interaction | H3C1 interactions | NUSAP1 NSD2 DHX38 DAXX CHD8 MORC2 NUPR1 DDB1 NSD3 AURKC NCOR1 MSH6 KMT2D TSR1 GNL2 DNM3 RACGAP1 PRKCA PRKCB POLD3 JHY | 2.75e-06 | 901 | 148 | 21 | int:H3C1 |
| Interaction | GRK2 interactions | 2.76e-06 | 119 | 148 | 8 | int:GRK2 | |
| Interaction | AURKB interactions | ZSWIM8 MYH11 PPAN NPIPB15 NOP53 NUPR1 HSP90AA5P DDB1 DHX9 AURKC MSH6 TARS3 TSR1 RACGAP1 CEP152 CRYBG3 HSP90AA1 UTP14C HSP90AB1 | 3.21e-06 | 761 | 148 | 19 | int:AURKB |
| Interaction | LATS1 interactions | MYH1 MYH2 MYH6 CEP85 TNC MINK1 CCDC77 DDB1 SVIL RACGAP1 CEP152 MAP4K4 GOLGA2 HSP90AB1 | 4.68e-06 | 440 | 148 | 14 | int:LATS1 |
| Interaction | H2BC8 interactions | NUSAP1 DDX59 NSD2 DHX38 CHD8 MORC2 ELAC2 NSD3 HMG20A MSH6 ZNF24 PTPN11 TSR1 GNL2 RACGAP1 POLD3 | 5.40e-06 | 576 | 148 | 16 | int:H2BC8 |
| Interaction | CHAT interactions | 7.89e-06 | 18 | 148 | 4 | int:CHAT | |
| Interaction | H3C3 interactions | NUSAP1 NSD2 DAXX CHD8 MORC2 DDB1 NSD3 HMG20A MSH6 ZNF24 TSR1 GNL2 RACGAP1 SENP7 | 1.77e-05 | 495 | 148 | 14 | int:H3C3 |
| Interaction | CASR interactions | 1.84e-05 | 22 | 148 | 4 | int:CASR | |
| Interaction | MEN1 interactions | ATXN2L PPAN CDC42BPA NOP53 DHX38 DAXX CHD8 NUPR1 INTS8 DDB1 NSD3 DHX9 NCOR1 KMT2D TSR1 GNL2 RACGAP1 MRTO4 MED12 GOLGA2 HSP90AA1 | 2.08e-05 | 1029 | 148 | 21 | int:MEN1 |
| Interaction | CDK3 interactions | 2.13e-05 | 114 | 148 | 7 | int:CDK3 | |
| Interaction | CSNK2A2 interactions | PPAN ACACA NOP53 MINK1 SPART DAXX NUPR1 DDB1 STRIP1 BNIP1 PTPRC TSR1 PRKCA ANKRD36 GRAMD1C HSP90AA1 HSP90AB1 | 2.17e-05 | 718 | 148 | 17 | int:CSNK2A2 |
| Interaction | MECP2 interactions | NUSAP1 ATXN2L NSUN4 CDC42BPA NSD2 TRIOBP INTS8 DDB1 THOC5 STT3B NSD3 HMG20A DHX9 ITGB3BP NCOR1 MSH6 TSR1 CFAP20 GNL2 DNM3 MAP4K4 MED12 HSP90AA1 HSP90AB1 | 2.22e-05 | 1287 | 148 | 24 | int:MECP2 |
| Interaction | CSNK2A1 interactions | PPAN ACACA NOP53 MINK1 DHX38 DAXX MORC2 NUPR1 DDB1 THOC5 HMG20A NCOR1 MSH6 IFRD1 PTPRC TSR1 ANKRD36 GRAMD1C HSP90AA1 HSP90AB1 | 2.35e-05 | 956 | 148 | 20 | int:CSNK2A1 |
| Interaction | ARL5A interactions | 2.67e-05 | 118 | 148 | 7 | int:ARL5A | |
| Interaction | SLC9A8 interactions | 3.13e-05 | 25 | 148 | 4 | int:SLC9A8 | |
| Interaction | HECTD1 interactions | NUSAP1 ATXN2L NSUN4 PPAN ACACA NSD2 NOP53 ATG14 DDB1 DHX9 MSH6 TSR1 GNL2 DNM3 RACGAP1 ERC2 MRTO4 ZBTB11 MED12 HSP90AB1 | 3.53e-05 | 984 | 148 | 20 | int:HECTD1 |
| Interaction | H3-3A interactions | NUSAP1 NSD2 DYNC2I1 DAXX CHD8 MORC2 DDB1 NSD3 HMG20A MSH6 ZNF24 KMT2D TSR1 GNL2 RACGAP1 ZBTB11 SENP7 | 3.70e-05 | 749 | 148 | 17 | int:H3-3A |
| Interaction | PRKCE interactions | 4.26e-05 | 173 | 148 | 8 | int:PRKCE | |
| Interaction | DDX46 interactions | 4.71e-05 | 227 | 148 | 9 | int:DDX46 | |
| Interaction | SUPT5H interactions | DHX38 ICE1 NUPR1 INTS8 NCOR1 MSH6 KMT2D SYNE2 MRTO4 SLX4 GOLGA2 HSP90AA1 | 4.95e-05 | 408 | 148 | 12 | int:SUPT5H |
| Interaction | SVIL interactions | 5.76e-05 | 233 | 148 | 9 | int:SVIL | |
| Interaction | KDM1A interactions | KIAA0408 ACACA NSD2 CHD8 CAGE1 ICE1 DDB1 HMG20A ITGB3BP NCOR1 MSH6 KMT2D N4BP2 ASCC2 CEP152 CRYBG3 KLHDC4 MED12 GOLGA2 | 6.15e-05 | 941 | 148 | 19 | int:KDM1A |
| Interaction | KCTD13 interactions | ATXN2L MYH6 MYH11 HTRA1 MYO9A TNC ITSN1 SPTB MINK1 TOM1 PFDN2 DDB1 STRIP1 DHX9 TARS3 SVIL PRKCA PRKCB ERC2 PRKCG TRAPPC9 HSP90AA1 CNTN1 HSP90AB1 | 7.90e-05 | 1394 | 148 | 24 | int:KCTD13 |
| Interaction | LYN interactions | ATP7A CDC42BPA NSD2 ITSN1 MINK1 MCAM NUPR1 PTPRC TSR1 SVIL RACGAP1 PRKCB RELL1 MAP4K4 HSP90AA1 HSP90AB1 | 8.13e-05 | 720 | 148 | 16 | int:LYN |
| Interaction | CBX3 interactions | NSD2 DHX38 DAXX CHD8 MORC2 NUPR1 DDB1 NSD3 NCOR1 ZNF24 TSR1 POLD3 MAP4K4 SLX4 SENP7 | 8.45e-05 | 646 | 148 | 15 | int:CBX3 |
| Interaction | MKI67 interactions | PPAN NSD2 NOP53 DAXX CHD8 NUPR1 THOC5 KMT2D GNL2 DNM3 RACGAP1 PRKCB MRTO4 MED12 SLX4 | 8.74e-05 | 648 | 148 | 15 | int:MKI67 |
| Interaction | KIF20A interactions | NUSAP1 MYH11 PPAN SPTB MINK1 CHD8 MORC2 HSP90AA5P DDB1 NSD3 HMG20A DHX9 SAMD9L SVIL SYNE2 RACGAP1 MRTO4 CRYBG3 MAP4K4 HSP90AB1 | 8.90e-05 | 1052 | 148 | 20 | int:KIF20A |
| Interaction | RIT1 interactions | PPAN CEP85 CHMP6 ACACA NPIPB9 NOP53 DHX38 PFDN2 ICE1 ELAC2 THOC5 DHX9 CHMP7 IFRD1 PTPN11 NPIPB6 CFAP20 WBP4 GNL2 RACGAP1 MRTO4 POLD3 | 9.39e-05 | 1230 | 148 | 22 | int:RIT1 |
| Interaction | GJA1 interactions | MYH6 ATP7A CDC42BPA ITSN1 MINK1 MCAM ATG14 SYNE2 PRKCA PRKCB PRKCG RELL1 MAP4K4 GOLGA2 | 1.03e-04 | 583 | 148 | 14 | int:GJA1 |
| Interaction | CDKL4 interactions | 1.05e-04 | 13 | 148 | 3 | int:CDKL4 | |
| Interaction | CENPA interactions | NSD2 NOP53 MORC2 DDB1 NSD3 HMG20A AURKC MSH6 TSR1 GNL2 RACGAP1 | 1.10e-04 | 377 | 148 | 11 | int:CENPA |
| Interaction | MAP4K4 interactions | 1.11e-04 | 254 | 148 | 9 | int:MAP4K4 | |
| Interaction | SPDL1 interactions | ATXN2L NSUN4 MYH11 ITSN1 DDB1 DHX9 MSH6 SLX4 HSP90AA1 HSP90AB1 | 1.15e-04 | 315 | 148 | 10 | int:SPDL1 |
| Interaction | ZNF330 interactions | NUSAP1 NSD2 NOP53 MORC2 NSD3 HMG20A MSH6 ZNF24 TSR1 GNL2 RACGAP1 ZBTB11 | 1.15e-04 | 446 | 148 | 12 | int:ZNF330 |
| Interaction | PSKH1 interactions | 1.16e-04 | 65 | 148 | 5 | int:PSKH1 | |
| Interaction | REV1 interactions | 1.22e-04 | 35 | 148 | 4 | int:REV1 | |
| Interaction | LRRC31 interactions | 1.40e-04 | 205 | 148 | 8 | int:LRRC31 | |
| Interaction | GSK3A interactions | ACACA MYO9A HELB TSR1 PRKCA PRKCB PRKCG CEP152 CRYBG3 SLX4 HSP90AA1 HSP90AB1 | 1.66e-04 | 464 | 148 | 12 | int:GSK3A |
| Interaction | CDC14B interactions | 1.69e-04 | 158 | 148 | 7 | int:CDC14B | |
| Interaction | CTTNBP2NL interactions | 1.88e-04 | 72 | 148 | 5 | int:CTTNBP2NL | |
| Interaction | EP300 interactions | PPAN ACACA NOP53 DHX38 SPART DAXX NUPR1 DDB1 STT3B DHX9 NCOR1 MSH6 IFRD1 ZNF24 KMT2D TSR1 N4BP2 WBP4 DNM3 PRKCA PRKCB MRTO4 GOLGA2 | 2.28e-04 | 1401 | 148 | 23 | int:EP300 |
| Interaction | WHAMMP3 interactions | 2.49e-04 | 119 | 148 | 6 | int:WHAMMP3 | |
| Interaction | PTK2B interactions | 2.49e-04 | 119 | 148 | 6 | int:PTK2B | |
| Interaction | CHUK interactions | 2.55e-04 | 224 | 148 | 8 | int:CHUK | |
| Interaction | SHCBP1 interactions | 2.58e-04 | 77 | 148 | 5 | int:SHCBP1 | |
| Interaction | SNRNP40 interactions | ACACA NSD2 NOP53 DHX38 PFDN2 NUPR1 DDB1 NSD3 HMG20A NCOR1 WBP4 GNL2 ZBTB11 MED12 | 2.58e-04 | 637 | 148 | 14 | int:SNRNP40 |
| Interaction | DHX38 interactions | 2.65e-04 | 170 | 148 | 7 | int:DHX38 | |
| Interaction | POLR1G interactions | NSD2 NOP53 DHX38 CHD8 PFDN2 ICE1 MORC2 NSD3 ZNF24 TSR1 GNL2 ZBTB11 | 2.69e-04 | 489 | 148 | 12 | int:POLR1G |
| Interaction | KRT18 interactions | CDC42BPA CCDC77 NUPR1 PTPN11 N4BP2 SVIL PRKCA CEP152 CRYBG3 GOLGA2 CNTN1 | 2.75e-04 | 419 | 148 | 11 | int:KRT18 |
| Interaction | PPIA interactions | CEP85 SAMD9 NSD2 ITSN1 DAXX CHD8 DDB1 ELAC2 WBP4 RACGAP1 N4BP2L2 ANKRD36 CRYBG3 MED12 SLX4 GOLGA2 SENP7 | 2.88e-04 | 888 | 148 | 17 | int:PPIA |
| Interaction | ADCK1 interactions | 2.91e-04 | 79 | 148 | 5 | int:ADCK1 | |
| Interaction | RGS2 interactions | 3.08e-04 | 80 | 148 | 5 | int:RGS2 | |
| Interaction | NRGN interactions | 3.45e-04 | 19 | 148 | 3 | int:NRGN | |
| Interaction | MYO1G interactions | 3.45e-04 | 19 | 148 | 3 | int:MYO1G | |
| Interaction | H2AC4 interactions | DAXX CHD8 DTX3L DDB1 HMG20A DHX9 KMT2D USF3 USP51 SVIL RACGAP1 SLX4 | 3.66e-04 | 506 | 148 | 12 | int:H2AC4 |
| Interaction | MOB3C interactions | ACACA NOP53 MINK1 PFDN2 DDB1 MSH6 TSR1 MAP4K4 HSP90AA1 HSP90AB1 | 3.67e-04 | 364 | 148 | 10 | int:MOB3C |
| Interaction | CIT interactions | ATXN2L MYH11 PPAN KIF27 NOP53 SPTB DHX38 CHD8 NUPR1 DDB1 THOC5 DHX9 MSH6 TSR1 CFAP20 SVIL SYNE2 GNL2 RACGAP1 GRAMD1C HSP90AA1 UTP14C HSP90AB1 | 3.72e-04 | 1450 | 148 | 23 | int:CIT |
| Interaction | SIRT7 interactions | ATXN2L ZSWIM8 ACACA NSD2 NOP53 DHX38 CHD8 DDB1 MSH6 TSR1 SYNE2 GNL2 MRTO4 ZBTB11 MED12 | 3.88e-04 | 744 | 148 | 15 | int:SIRT7 |
| Interaction | SMC5 interactions | ATXN2L MYH1 ACACA NSD2 NOP53 CHD8 ICE1 NSD3 HMG20A DHX9 NCOR1 IFRD1 WBP4 GNL2 RACGAP1 SLX4 HSP90AA1 HSP90AB1 | 3.97e-04 | 1000 | 148 | 18 | int:SMC5 |
| Interaction | GRK5 interactions | 4.00e-04 | 182 | 148 | 7 | int:GRK5 | |
| Interaction | SNW1 interactions | KIF27 DHX38 DAXX CHD8 DDB1 DHX9 NCOR1 MSH6 WBP4 ASCC2 RACGAP1 SLX4 GOLGA2 HSP90AA1 HSP90AB1 | 4.05e-04 | 747 | 148 | 15 | int:SNW1 |
| Interaction | AGO1 interactions | 4.14e-04 | 183 | 148 | 7 | int:AGO1 | |
| Interaction | NR1I3 interactions | 4.23e-04 | 48 | 148 | 4 | int:NR1I3 | |
| Interaction | DGCR8 interactions | 4.28e-04 | 242 | 148 | 8 | int:DGCR8 | |
| Interaction | FKBP6 interactions | 4.31e-04 | 86 | 148 | 5 | int:FKBP6 | |
| Interaction | YWHAH interactions | ATXN2L NSUN4 MYH11 CDC42BPA MYO9A MINK1 DHX38 PFDN2 NSD3 SVIL SYNE2 RACGAP1 CEP152 CRYBG3 MAP4K4 SH3RF3 TRAPPC9 HSP90AA1 HSP90AB1 | 4.63e-04 | 1102 | 148 | 19 | int:YWHAH |
| Interaction | PDIK1L interactions | 4.68e-04 | 21 | 148 | 3 | int:PDIK1L | |
| Interaction | MNDA interactions | 4.86e-04 | 188 | 148 | 7 | int:MNDA | |
| Interaction | ZBTB2 interactions | 5.02e-04 | 450 | 148 | 11 | int:ZBTB2 | |
| Interaction | NDC80 interactions | 5.09e-04 | 312 | 148 | 9 | int:NDC80 | |
| Interaction | SRPK3 interactions | 5.18e-04 | 190 | 148 | 7 | int:SRPK3 | |
| Cytoband | 16p13.11 | 1.40e-08 | 23 | 157 | 5 | 16p13.11 | |
| Cytoband | 16p11.2 | 5.38e-05 | 191 | 157 | 6 | 16p11.2 | |
| GeneFamily | Myosin heavy chains | 8.57e-07 | 15 | 93 | 4 | 1098 | |
| GeneFamily | C2 domain containing protein kinases | 1.54e-05 | 10 | 93 | 3 | 835 | |
| GeneFamily | PWWP domain containing | 1.89e-04 | 22 | 93 | 3 | 1147 | |
| GeneFamily | Heat shock 90kDa proteins | 2.59e-04 | 5 | 93 | 2 | 586 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 7.02e-04 | 34 | 93 | 3 | 487 | |
| GeneFamily | Cytochrome P450 family 2 | 7.65e-04 | 35 | 93 | 3 | 1001 | |
| GeneFamily | Anoctamins | 1.15e-03 | 10 | 93 | 2 | 865 | |
| GeneFamily | Charged multivesicular body proteins|ESCRT-III associated factors | 1.40e-03 | 11 | 93 | 2 | 482 | |
| GeneFamily | DEAH-box helicases | 3.00e-03 | 16 | 93 | 2 | 500 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.23e-03 | 206 | 93 | 5 | 682 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 4.68e-03 | 20 | 93 | 2 | 1371 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | NUSAP1 NSUN4 CEP85 NSD2 ELAC2 NSD3 ITGB3BP MSH6 IFRD1 PTPN11 BNIP1 TSR1 N4BP2 GNL2 RACGAP1 PRKCB TRMT13 MRTO4 CEP152 POLD3 HSP90AA1 HSP90AB1 | 4.97e-06 | 1290 | 151 | 22 | M80 |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_ENDOTHELIAL_CELLS | ATXN2L PPAN DTX3L MORC2 STT3B PTPN11 USF3 MRTO4 RELL1 MED12 HSP90AB1 | 7.34e-06 | 356 | 151 | 11 | M43609 |
| Coexpression | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C | NUSAP1 PPAN CEP85 NSD2 NSD3 DHX9 NCOR1 GRK3 SYNE2 CEP152 POLD3 KLHDC4 | 1.35e-05 | 454 | 151 | 12 | M19927 |
| Coexpression | GSE22886_NAIVE_VS_MEMORY_TCELL_UP | 1.75e-05 | 194 | 151 | 8 | M4416 | |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 1.82e-05 | 195 | 151 | 8 | M13736 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SAMD9 NOP53 CCDC186 ICE1 DTX3L NPIPA7 NSD3 USF3 SAMD9L SYNE2 | 7.81e-10 | 177 | 157 | 10 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SAMD9 NOP53 CCDC186 ICE1 DTX3L NPIPA7 NSD3 USF3 SAMD9L SYNE2 | 7.81e-10 | 177 | 157 | 10 | f8f101c772c043636bedd6b2ec81409b1d2599bf |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | SAMD9 NOP53 CCDC186 ICE1 DTX3L NPIPA7 NSD3 USF3 SAMD9L SYNE2 | 7.81e-10 | 177 | 157 | 10 | 6978a22fef40c8b455342373abe7593f5ede0fa4 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | SAMD9 NOP53 CCDC186 ICE1 DTX3L NPIPA7 NSD3 USF3 SAMD9L SYNE2 | 7.81e-10 | 177 | 157 | 10 | 936ab2b180a052387124f68d0c7f41c0b164e748 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | SAMD9 NOP53 CCDC186 ICE1 DTX3L NPIPA7 NSD3 USF3 SAMD9L SYNE2 | 7.81e-10 | 177 | 157 | 10 | d5aeda113afaa2425874394610344570c9078478 |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 1.89e-08 | 183 | 157 | 9 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.19e-08 | 155 | 157 | 8 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.74e-07 | 171 | 157 | 8 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.74e-07 | 143 | 157 | 7 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-06 | 175 | 157 | 7 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-06 | 183 | 157 | 7 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | Mild/Remission-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.53e-06 | 121 | 157 | 6 | 68940a552233d255b90ce5a081339c0d9d46ab02 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-06 | 190 | 157 | 7 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-06 | 190 | 157 | 7 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.49e-06 | 192 | 157 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.68e-06 | 193 | 157 | 7 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | Severe-B_intermediate-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.72e-06 | 126 | 157 | 6 | 42a0bdbe18ef85146cac4e86b2b27d0b3b20d8a2 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.87e-06 | 194 | 157 | 7 | 0b0042b6a356a49a059fb64a1e1abb25c82d48cf | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.87e-06 | 194 | 157 | 7 | 9588a9b4baebbae08e13d201d4b9dfcf0e6521fb | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.49e-06 | 197 | 157 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 6.93e-06 | 199 | 157 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 6.93e-06 | 199 | 157 | 7 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 9.64e-06 | 138 | 157 | 6 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.73e-05 | 153 | 157 | 6 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.16e-05 | 159 | 157 | 6 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.84e-05 | 167 | 157 | 6 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.84e-05 | 167 | 157 | 6 | 1c1b4722c6c0eff85a9b32ca7b4e281caebf63b0 | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 3.35e-05 | 172 | 157 | 6 | 0657c736f3c52d25cf7f652eac005ddcde9232ef | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.81e-05 | 176 | 157 | 6 | 45c6983ab671b0f306e7390320bd84f848e474cc | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 178 | 157 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_B3-4|TCGA-Thymus / Sample_Type by Project: Shred V9 | 4.42e-05 | 110 | 157 | 5 | 56e93e8d0d6232ab9090f685e5e4803ef79b2567 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.60e-05 | 182 | 157 | 6 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 4.60e-05 | 182 | 157 | 6 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.60e-05 | 182 | 157 | 6 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.60e-05 | 182 | 157 | 6 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.60e-05 | 182 | 157 | 6 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 4.74e-05 | 183 | 157 | 6 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 4.74e-05 | 183 | 157 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.74e-05 | 183 | 157 | 6 | b4f29dd3994009bb5eb769d36d95886664e7f87d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.74e-05 | 183 | 157 | 6 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.88e-05 | 184 | 157 | 6 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.88e-05 | 184 | 157 | 6 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.88e-05 | 184 | 157 | 6 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | (1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.50e-05 | 188 | 157 | 6 | b8f67ac2faadd5b848955e43ab5d6cf5e49b3681 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.50e-05 | 188 | 157 | 6 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.50e-05 | 188 | 157 | 6 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-05 | 189 | 157 | 6 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 5.83e-05 | 190 | 157 | 6 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.83e-05 | 190 | 157 | 6 | f6616b3fe7f4962249503c96c06926240066d861 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.83e-05 | 190 | 157 | 6 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.83e-05 | 190 | 157 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-05 | 191 | 157 | 6 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.01e-05 | 191 | 157 | 6 | c5e22df4a8741b8096cdd1618271fd48d6265846 | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 6.01e-05 | 191 | 157 | 6 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-05 | 191 | 157 | 6 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-05 | 191 | 157 | 6 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | MatrixFB-Fibroblast-D_(Pericyte)|MatrixFB / shred on cell class and cell subclass (v4) | 6.18e-05 | 192 | 157 | 6 | 630444302511f511ec6976bc045a3b4b9d8d4547 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.18e-05 | 192 | 157 | 6 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.36e-05 | 193 | 157 | 6 | 2901d7a9672a8cf70c9f1c752685b45e4d79ac70 | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.36e-05 | 193 | 157 | 6 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 6.36e-05 | 193 | 157 | 6 | beb862d38b88572836b0a797c8efef7a2492e0b9 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.36e-05 | 193 | 157 | 6 | f4310faa13fc8ce99a217e2d1c9cc733683797a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.36e-05 | 193 | 157 | 6 | f8af695457d2a0a911a5ac491742465864ebda37 | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.36e-05 | 193 | 157 | 6 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.36e-05 | 193 | 157 | 6 | 089aece40130034a89a5213be778f10b0787eeba | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 194 | 157 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 195 | 157 | 6 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 6.74e-05 | 195 | 157 | 6 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 6.74e-05 | 195 | 157 | 6 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.74e-05 | 195 | 157 | 6 | 53528e5788083bce5a8d4611ab3808878e6a9cd3 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.74e-05 | 195 | 157 | 6 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 195 | 157 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-05 | 196 | 157 | 6 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | Mild|World / Disease group and Cell class | 6.93e-05 | 196 | 157 | 6 | 5e4ed4a5a437cfa002b92775992a791e27aa4c27 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-05 | 196 | 157 | 6 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.93e-05 | 196 | 157 | 6 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.13e-05 | 197 | 157 | 6 | 3332b9b5bf78f0203ebbd94257a36e9054d896c3 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.13e-05 | 197 | 157 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-05 | 197 | 157 | 6 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 7.13e-05 | 197 | 157 | 6 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-05 | 197 | 157 | 6 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.13e-05 | 197 | 157 | 6 | e132f4b9deef6a565262c0aa0863cafe28f248e6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-05 | 197 | 157 | 6 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.33e-05 | 198 | 157 | 6 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | CV|World / Virus stimulation, Condition and Cluster | 7.33e-05 | 198 | 157 | 6 | 6a28193af35abec5c029129930c2ca6febaafde2 | |
| ToppCell | CD8+_Memory_T_cell-CV|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.33e-05 | 198 | 157 | 6 | 3d1749f5106f0912f4a74615863853949f52c73d | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-Treg|Influenza_Severe / Disease, condition lineage and cell class | 7.33e-05 | 198 | 157 | 6 | e377fa0215f338f86ee2903ce3fa57cea805a630 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.33e-05 | 198 | 157 | 6 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.53e-05 | 199 | 157 | 6 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 7.53e-05 | 199 | 157 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 7.53e-05 | 199 | 157 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.53e-05 | 199 | 157 | 6 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 7.53e-05 | 199 | 157 | 6 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.75e-05 | 200 | 157 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.75e-05 | 200 | 157 | 6 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 7.75e-05 | 200 | 157 | 6 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 7.75e-05 | 200 | 157 | 6 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-Treg|Int-URO / Disease, condition lineage and cell class | 7.75e-05 | 200 | 157 | 6 | 47f265336bc3b8052c0cac730ac9afd41cd8fc43 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 7.75e-05 | 200 | 157 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.75e-05 | 200 | 157 | 6 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| Drug | 2'-methoxyacetophenone | 2.80e-07 | 3 | 150 | 3 | CID000068481 | |
| Drug | nifedipine | MYH1 MYH2 CYP2A6 CYP2A7 CYP3A7 MYH6 CYP2A13 MYH11 GRM6 MYO3A GRK3 PRKCA PRKCB PRKCG | 6.79e-07 | 415 | 150 | 14 | CID000004485 |
| Drug | SC-10 | 1.01e-06 | 28 | 150 | 5 | CID000005175 | |
| Drug | formycin triphosphate | 1.04e-06 | 51 | 150 | 6 | CID000122274 | |
| Drug | mepivacaine | 1.04e-06 | 51 | 150 | 6 | CID000004062 | |
| Drug | trifluoperazine | MYH1 MYH2 MYH6 MYH11 ACACA MYO9A TNC MYO3A GRK3 PRKCA PRKCB PRKCG | 1.68e-06 | 324 | 150 | 12 | CID000005566 |
| Drug | SM-2 | 1.76e-06 | 87 | 150 | 7 | CID000486033 | |
| Drug | purealin | 2.26e-06 | 58 | 150 | 6 | CID006419303 | |
| Drug | S-(-)-Etomoxir | 4.49e-06 | 100 | 150 | 7 | CID000060765 | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; PC3; HT_HG-U133A | 5.33e-06 | 192 | 150 | 9 | 3804_DN | |
| Drug | AC1L1IZ2 | MYH1 MYH2 MYH6 MYH11 ATP7A MYO9A PANX2 STT3B MYO3A GRK3 HSP90AA1 | 5.77e-06 | 304 | 150 | 11 | CID000004795 |
| Drug | Meptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 6.05e-06 | 195 | 150 | 9 | 7326_UP | |
| Drug | sapintoxin A | 6.50e-06 | 19 | 150 | 4 | CID000108085 | |
| Drug | arachidonyl trifluoromethyl ketone; Down 200; 10uM; MCF7; HG-U133A | 6.84e-06 | 198 | 150 | 9 | 594_DN | |
| Drug | ruboxistaurin | 7.04e-06 | 107 | 150 | 7 | CID000153999 | |
| Drug | fast white | 8.11e-06 | 42 | 150 | 5 | CID000024008 | |
| Drug | AC1ND2OB | MYH1 CYP2A6 CYP3A7 MYH11 NCOR1 PTPN11 PRKCA PRKCB PRKCG MED12 | 1.08e-05 | 265 | 150 | 10 | CID004568637 |
| Drug | B0683 | 1.27e-05 | 117 | 150 | 7 | CID006398969 | |
| Drug | 19-HETE | 1.75e-05 | 49 | 150 | 5 | CID006439528 | |
| Drug | 2bq7 | 1.76e-05 | 123 | 150 | 7 | CID006540267 | |
| Drug | D-triiodothyronine | MYH1 MYH2 MYH6 MYH11 ACACA NCOR1 MYO3A CFAP20 PRKCA PRKCB PRKCG MED12 | 1.78e-05 | 409 | 150 | 12 | CID000000861 |
| Drug | N-desmethyl-tamoxifen-hydrochloride | 2.35e-05 | 52 | 150 | 5 | CID000035887 | |
| Drug | AC1LADJ6 | 2.51e-05 | 130 | 150 | 7 | CID000486032 | |
| Drug | 9-hydroxybenzo(a)pyrene | 2.58e-05 | 53 | 150 | 5 | CID000028598 | |
| Drug | BP-9,10-oxide | 2.82e-05 | 27 | 150 | 4 | CID000037456 | |
| Drug | Brn 4136738 | 2.82e-05 | 27 | 150 | 4 | CID000050331 | |
| Drug | C14845 | 2.82e-05 | 27 | 150 | 4 | CID011954064 | |
| Drug | 5-nitro-1-naphthonitrile | 3.28e-05 | 28 | 150 | 4 | CID000031744 | |
| Drug | 9-OH-BaP-4,5-oxide | 3.28e-05 | 28 | 150 | 4 | CID000115064 | |
| Drug | propargyl ether | 4.31e-05 | 2 | 150 | 2 | ctd:C531209 | |
| Drug | 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine | 4.31e-05 | 2 | 150 | 2 | DB02754 | |
| Drug | 12-hydroxydaphnetoxin | 4.31e-05 | 2 | 150 | 2 | CID000099841 | |
| Drug | Hempa | 4.31e-05 | 2 | 150 | 2 | ctd:D006492 | |
| Drug | Geldanamycin | 4.31e-05 | 2 | 150 | 2 | DB02424 | |
| Drug | 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE | 4.31e-05 | 2 | 150 | 2 | DB07877 | |
| Drug | nicotine imine | 4.31e-05 | 2 | 150 | 2 | ctd:C034629 | |
| Drug | 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL | 4.31e-05 | 2 | 150 | 2 | DB07594 | |
| Drug | alpha-nicotyrine | 4.31e-05 | 2 | 150 | 2 | ctd:C008615 | |
| Drug | N-nitrosoguvacoline | 4.31e-05 | 2 | 150 | 2 | ctd:C036676 | |
| Drug | 19-hydroxytestosterone | 4.34e-05 | 30 | 150 | 4 | CID000150968 | |
| Drug | 11-H-14,15-EETA | 4.34e-05 | 30 | 150 | 4 | CID011954058 | |
| Drug | NSC339663 | 4.35e-05 | 250 | 150 | 9 | CID000003892 | |
| Drug | Ro-31-8425 | 4.74e-05 | 60 | 150 | 5 | CID000002404 | |
| Drug | 1,1-dichloroethylene | 4.74e-05 | 60 | 150 | 5 | CID000006366 | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 7420_DN | |
| Drug | Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; HL60; HG-U133A | 5.39e-05 | 199 | 150 | 8 | 1991_UP | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Up 200; 10uM; HL60; HG-U133A | 5.39e-05 | 199 | 150 | 8 | 1582_UP | |
| Drug | Ricinine [524-40-3]; Down 200; 24.4uM; MCF7; HT_HG-U133A | 5.59e-05 | 200 | 150 | 8 | 6206_DN | |
| Drug | BP-7,8-oxide | 5.64e-05 | 32 | 150 | 4 | CID000037455 | |
| Drug | bryostatin 1 | 5.90e-05 | 12 | 150 | 3 | ctd:C046785 | |
| Drug | 4-chloroaniline | 5.99e-05 | 202 | 150 | 8 | CID000007812 | |
| Drug | 12(13)-EpOME | 7.20e-05 | 34 | 150 | 4 | CID000001416 | |
| Drug | TCEO | 7.20e-05 | 34 | 150 | 4 | CID000028167 | |
| Drug | AC1O5XSP | 7.20e-05 | 34 | 150 | 4 | CID006442739 | |
| Drug | phosphine oxide | 7.73e-05 | 107 | 150 | 6 | CID000166931 | |
| Drug | AC1L1CJI | 8.08e-05 | 35 | 150 | 4 | CID000001929 | |
| Drug | 15-H-11,12-EETA | 9.05e-05 | 36 | 150 | 4 | CID011954042 | |
| Drug | AC1L3NGJ | 9.05e-05 | 36 | 150 | 4 | CID000092121 | |
| Drug | N-nitrosomethylaniline | 9.67e-05 | 14 | 150 | 3 | CID000011957 | |
| Drug | 1h1q | 9.95e-05 | 70 | 150 | 5 | CID000001540 | |
| Drug | 4-bromophenol | 9.95e-05 | 70 | 150 | 5 | CID000007808 | |
| Drug | 2-amino-4,6-dinitrotoluene | 9.95e-05 | 70 | 150 | 5 | ctd:C035208 | |
| Drug | HOE 694 | 1.01e-04 | 37 | 150 | 4 | CID000123840 | |
| Drug | 1,2-dibromoethane | 1.07e-04 | 71 | 150 | 5 | CID000007839 | |
| Drug | RK-1409B | 1.20e-04 | 15 | 150 | 3 | CID003036125 | |
| Drug | 1-stearoyl-2-arachidonylglycerol | 1.20e-04 | 15 | 150 | 3 | CID006443869 | |
| Drug | dansyl-DAG | 1.20e-04 | 15 | 150 | 3 | CID000129493 | |
| Drug | blebbistatin | 1.21e-04 | 116 | 150 | 6 | CID003476986 | |
| Drug | chloral | 1.22e-04 | 73 | 150 | 5 | CID000006407 | |
| Drug | NSC9700 | MYH1 MYH2 CYP2A6 CYP2A7 CYP3A7 MYH6 CYP2A13 MYH11 MYO3A PRKCA PRKCB PRKCG UTP14C | 1.22e-04 | 578 | 150 | 13 | CID000005408 |
| Drug | 11,14,15-THET | 1.24e-04 | 39 | 150 | 4 | CID006439531 | |
| Drug | octahydromezerein | 1.29e-04 | 3 | 150 | 2 | CID000164152 | |
| Drug | PKC412 | 1.30e-04 | 74 | 150 | 5 | CID009829523 | |
| Drug | 11,12,15-trihydroxyeicosatrienoic acid | 1.67e-04 | 42 | 150 | 4 | CID006439610 | |
| Drug | eye gene | 1.74e-04 | 369 | 150 | 10 | CID000004782 | |
| Drug | decursin | 1.78e-04 | 17 | 150 | 3 | CID000442126 | |
| Drug | AC1L1JQC | 1.78e-04 | 17 | 150 | 3 | CID000005157 | |
| Drug | daphnoretin | 1.78e-04 | 17 | 150 | 3 | CID005281406 | |
| Drug | polybrominated biphenyl | 2.00e-04 | 44 | 150 | 4 | CID000042948 | |
| Drug | NSC107658 | 2.02e-04 | 306 | 150 | 9 | CID000002919 | |
| Drug | resiniferonol | 2.13e-04 | 18 | 150 | 3 | CID000162824 | |
| Drug | dihydrosterculic acid | 2.13e-04 | 18 | 150 | 3 | CID000160788 | |
| Drug | dipalmitin | 2.13e-04 | 18 | 150 | 3 | CID000068149 | |
| Drug | Cgp-42700 | 2.13e-04 | 18 | 150 | 3 | CID000188390 | |
| Drug | chloral hydrate | 2.16e-04 | 129 | 150 | 6 | CID000002707 | |
| Drug | naphthalene-1,2-dihydrodiol | 2.19e-04 | 45 | 150 | 4 | CID000000362 | |
| Drug | 1 Em | 2.23e-04 | 83 | 150 | 5 | CID000446621 | |
| Drug | NPC 15437 | 2.38e-04 | 46 | 150 | 4 | CID000004548 | |
| Drug | TAPP-Br | 2.51e-04 | 19 | 150 | 3 | CID000160326 | |
| Drug | SR121463 | 2.51e-04 | 19 | 150 | 3 | CID000158348 | |
| Drug | N'-nitrosoanatabine | 2.56e-04 | 4 | 150 | 2 | ctd:C032978 | |
| Drug | N-(5-methylisoxazol-3-yl)-2-(4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidin-2-ylthio)acetamide | 2.56e-04 | 4 | 150 | 2 | ctd:C576667 | |
| Drug | daphnetoxin | 2.56e-04 | 4 | 150 | 2 | CID000119454 | |
| Drug | NMPA | 2.56e-04 | 4 | 150 | 2 | CID000132101 | |
| Drug | C14802 | 2.59e-04 | 47 | 150 | 4 | CID011954053 | |
| Drug | nitro-L | 2.81e-04 | 48 | 150 | 4 | CID000006849 | |
| Drug | C14800 | 2.81e-04 | 48 | 150 | 4 | CID011954051 | |
| Drug | phorbol 12,13-diacetate | 2.81e-04 | 48 | 150 | 4 | CID000072293 | |
| Drug | HepI | 2.94e-04 | 20 | 150 | 3 | CID003036968 | |
| Drug | bromobenzene-3,4-oxide | 3.05e-04 | 49 | 150 | 4 | CID000108121 | |
| Disease | Malignant neoplasm of breast | MYH1 FLT1 DDX59 NSD2 DTX3L PANX2 GRM6 THOC5 NCOR1 MSH6 KMT2D PTPRC N4BP2 SYNE2 WBP4 ANKRD30A MED12 HSP90AA1 | 6.43e-06 | 1074 | 146 | 18 | C0006142 |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.39e-05 | 10 | 146 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.39e-05 | 10 | 146 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.39e-05 | 10 | 146 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.39e-05 | 10 | 146 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.39e-05 | 10 | 146 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.39e-05 | 10 | 146 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.39e-05 | 10 | 146 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.39e-05 | 10 | 146 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Familial monosomy 7 syndrome | 2.43e-05 | 2 | 146 | 2 | cv:C5681220 | |
| Disease | distal myopathy (implicated_via_orthology) | 2.53e-05 | 12 | 146 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.53e-05 | 12 | 146 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 3.27e-05 | 13 | 146 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 5.17e-05 | 15 | 146 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Sotos syndrome 1 (implicated_via_orthology) | 7.27e-05 | 3 | 146 | 2 | DOID:0112103 (implicated_via_orthology) | |
| Disease | emphysema pattern measurement | 1.08e-04 | 19 | 146 | 3 | EFO_0005850 | |
| Disease | Malignant Cystosarcoma Phyllodes | 2.41e-04 | 5 | 146 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 2.41e-04 | 5 | 146 | 2 | C0010701 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 4.32e-04 | 71 | 146 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | platelet reactivity measurement, thrombus formation measurement | 5.02e-04 | 7 | 146 | 2 | EFO_0004985, EFO_0007615 | |
| Disease | diastolic blood pressure, systolic blood pressure | MYH6 FLT1 CEP85 MYO9A CAGE1 MSH6 N4BP2 SVIL GNL2 PRKCA TRAPPC9 | 5.24e-04 | 670 | 146 | 11 | EFO_0006335, EFO_0006336 |
| Disease | bitter non-alcoholic beverage consumption measurement | 5.30e-04 | 32 | 146 | 3 | EFO_0010093 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 6.80e-04 | 80 | 146 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | CYP2A6 SAMD9 ITSN1 GRPR ELAC2 NCOR1 KMT2D PTPRC MED12 HSP90AB1 | 1.02e-03 | 616 | 146 | 10 | C0033578 |
| Disease | Malignant neoplasm of prostate | CYP2A6 SAMD9 ITSN1 GRPR ELAC2 NCOR1 KMT2D PTPRC MED12 HSP90AB1 | 1.02e-03 | 616 | 146 | 10 | C0376358 |
| Disease | Inherited neuropathies | 1.03e-03 | 40 | 146 | 3 | C0598589 | |
| Disease | nicotine metabolite ratio | 1.55e-03 | 12 | 146 | 2 | EFO_0007794 | |
| Disease | X-12707 measurement | 1.55e-03 | 12 | 146 | 2 | EFO_0800720 | |
| Disease | alpha fetoprotein measurement | 1.56e-03 | 100 | 146 | 4 | EFO_0010583 | |
| Disease | myopathy (implicated_via_orthology) | 1.74e-03 | 48 | 146 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | phosphatidylcholine 40:7 measurement | 1.83e-03 | 13 | 146 | 2 | EFO_0021477 | |
| Disease | cholesteryl ester 20:3 measurement | 1.85e-03 | 49 | 146 | 3 | EFO_0010347 | |
| Disease | sleep duration | 2.23e-03 | 362 | 146 | 7 | EFO_0005271 | |
| Disease | platelet-to-lymphocyte ratio | 2.27e-03 | 363 | 146 | 7 | EFO_0008446 | |
| Disease | Hepatitis C | 2.45e-03 | 15 | 146 | 2 | C0019196 | |
| Disease | Dementia | 3.15e-03 | 17 | 146 | 2 | C0497327 | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 3.15e-03 | 17 | 146 | 2 | DOID:10873 (is_implicated_in) | |
| Disease | Moyamoya Disease | 3.15e-03 | 17 | 146 | 2 | C0026654 | |
| Disease | syndrome (implicated_via_orthology) | 3.53e-03 | 18 | 146 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | Adrenocortical carcinoma | 3.53e-03 | 18 | 146 | 2 | C0206686 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.68e-03 | 206 | 146 | 5 | C0152013 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 3.93e-03 | 19 | 146 | 2 | OBA_2045199 | |
| Disease | caffeine metabolite measurement | 3.93e-03 | 19 | 146 | 2 | EFO_0007872 | |
| Disease | pulmonary non-tuberculous mycobacterial infection | 3.93e-03 | 19 | 146 | 2 | MONDO_0018469 | |
| Disease | etiocholanolone glucuronide measurement | 3.93e-03 | 19 | 146 | 2 | EFO_0800362 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 3.93e-03 | 19 | 146 | 2 | DOID:4928 (is_marker_for) | |
| Disease | Fetal Growth Retardation | 4.36e-03 | 20 | 146 | 2 | C0015934 | |
| Disease | androsterone glucuronide measurement | 4.36e-03 | 20 | 146 | 2 | EFO_0800317 | |
| Disease | testosterone measurement | ATXN2L MYH2 CYP3A7 KIF27 SLC22A11 SLC22A24 MSH6 SEMA6D SYNE2 DNM3 PRKCA ERC2 MED12 JHY | 4.43e-03 | 1275 | 146 | 14 | EFO_0004908 |
| Disease | MYELODYSPLASTIC SYNDROME | 4.51e-03 | 67 | 146 | 3 | C3463824 | |
| Disease | Nonorganic psychosis | 4.90e-03 | 69 | 146 | 3 | C0349204 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RKRHLHAVEGQKKVQ | 406 | Q8N715 | |
| KKKEQRVQHISQGKD | 566 | Q8N715 | |
| RNKIDVNEISRHLGK | 286 | Q86TW2 | |
| VRLQKAHARKNEKIE | 766 | Q7Z3E2 | |
| IEARKRAKNKQLGHE | 536 | P35626 | |
| ETIQKNKDQAHRLKG | 611 | Q8IYS0 | |
| KSQIEKEGLEHQLRR | 76 | Q9UQB9 | |
| RLEHQKKQEKANRIV | 451 | Q9HCK8 | |
| RKHKAVVEKIGEENN | 1201 | O94986 | |
| KLKHTNRKQEVRIQE | 311 | Q8TC20 | |
| LRKRNKTGKHDVQVL | 2246 | Q6UVK1 | |
| KVHEEIDRVIGKNRQ | 326 | P11509 | |
| VKIRQSEDKRNHAEK | 71 | Q68DQ2 | |
| KEENVKNHVEAAGRK | 701 | Q68DQ2 | |
| KKEKIQRHNRKLGDL | 161 | Q6ZNE5 | |
| QRHNRKLGDLVEKKT | 166 | Q6ZNE5 | |
| RISQKAERGAKVHQE | 296 | Q07092 | |
| ERRKKEANKATRANH | 726 | Q9H1I8 | |
| KIHKAASRGQVRKLE | 41 | Q9BXX3 | |
| NRRAHKIQGELKNLK | 461 | Q9BR77 | |
| GLHLVKQGRDRKKID | 81 | Q13085 | |
| RKHEDLQKALKRNGE | 1546 | A6QL64 | |
| ARGKRKGKNHVSNVV | 206 | Q6NUI1 | |
| RRKGFHIKVIRDQKQ | 61 | A1A5B4 | |
| GRKKQSRVTEQDKAI | 6 | Q96FZ7 | |
| RQRSVHEKNGKKICT | 651 | Q9UER7 | |
| NSKVNGEHKEKVLQR | 216 | Q8WWM7 | |
| HKVAKVKQLQEEGKR | 1281 | Q04656 | |
| SDKQNGRVAKVKGHR | 161 | Q96B23 | |
| QRIQAAEHKTRKDEK | 211 | Q8IZ41 | |
| HKRGETDKRQIAIKA | 946 | Q75QN2 | |
| VTTKVNRHDKINGKR | 126 | Q9UND3 | |
| NRHDKINGKRKTAKE | 131 | Q9UND3 | |
| QRKHGVRVKRKVQAL | 456 | Q9NW15 | |
| EEKRDQIIQGKHTKS | 516 | D6REC4 | |
| RRVKEVVKKHSQFIG | 196 | P08238 | |
| QLKDHIDRTRKKRGE | 301 | O95819 | |
| GKKRKAQREEEQEHS | 656 | Q13823 | |
| AHQVPNAKKLRRKEQ | 136 | Q9NZM5 | |
| VNKERGHKDQEEKRF | 466 | Q6NUN7 | |
| LEEQKKQGQDHRLKS | 346 | Q9Y692 | |
| RKTQDRQKGKSHRQD | 181 | Q9NP66 | |
| HSRRQKGKRENKVCV | 151 | P0DMR3 | |
| DKKVRNGHIKRITDN | 26 | Q9Y6A4 | |
| HSEKSQIERKNILKG | 476 | Q5T1V6 | |
| NLVRNHGKDKDSRRK | 316 | Q8WVS4 | |
| ANHIREREGKTKDQV | 461 | Q9UQ16 | |
| RRIKEIVKKHSQFIG | 31 | Q58FG0 | |
| QKRRHNVDEKLKNGR | 1031 | Q86VH2 | |
| KGKELNEFREKHNIR | 111 | Q9UHV9 | |
| QKRNAEAVKGLRKHE | 1836 | Q9UKX2 | |
| KRHVEQKIQFKRETA | 96 | A8MUH7 | |
| VNGKKRNHTKRIQDP | 521 | O96028 | |
| TTKINRHDKINGKRK | 181 | E9PQR5 | |
| RHDKINGKRKTARKQ | 186 | E9PQR5 | |
| NHKDGLRKENKREQS | 96 | Q6ZU52 | |
| DQRAERILHKEQGKT | 236 | Q9H3U5 | |
| GKQRDDARHAIKKIT | 761 | Q93074 | |
| ARKGALRQKNVHEVK | 21 | P05771 | |
| RKGALRQKVVHEVKS | 21 | P05129 | |
| RNVEAVKGLRKHERK | 1836 | P12882 | |
| KREKDRLVHQLKQQT | 891 | O15083 | |
| QRRIEEEQKSKRKGH | 526 | Q06124 | |
| KVTTKINRHDKINGK | 161 | O75200 | |
| INRHDKINGKRKTAR | 166 | O75200 | |
| VTTKVNRHDKINGKR | 126 | F8WFD2 | |
| NRHDKINGKRKTAKE | 131 | F8WFD2 | |
| PHLQTKEEQRKKREQ | 406 | Q9BXS6 | |
| EVIQKGHRKAREFEK | 1311 | P52701 | |
| TTKVNRHDKINGKRK | 146 | E9PIF3 | |
| QSEQHVKRELGKKLG | 571 | Q08379 | |
| KVTTKINRHDKINGK | 161 | A6NHN6 | |
| INRHDKINGKRKTAR | 166 | A6NHN6 | |
| AQKDKGLHVEVRVNR | 791 | Q9Y6X9 | |
| HEEENNIFKRSRKKE | 266 | Q96CB9 | |
| KVTTKINRHDKINGK | 161 | E5RHQ5 | |
| INRHDKINGKRKTAR | 166 | E5RHQ5 | |
| EEQKHRNGLSNEKRK | 51 | Q13352 | |
| KKLREKQKVIRESHG | 616 | Q8WYA0 | |
| SKQKNEKELRHIGTQ | 176 | Q9Y2F5 | |
| VVTNKHRVKVELKNG | 221 | Q92743 | |
| HPEQNVQKRKRSLKA | 846 | O15303 | |
| KVHEEIDRVIGKNRQ | 326 | Q16696 | |
| RAAKERVLKKGEHQI | 61 | Q8TDB6 | |
| KAKQRTEKRIEALHA | 286 | Q8WUX9 | |
| KVHEEIDRVIGKNRQ | 326 | P20853 | |
| VEGNIHVKKQIESRK | 246 | P30550 | |
| NDKKHQLEGKLQDIR | 486 | Q15811 | |
| KQRKHISQLEQKVRE | 346 | Q6P2H3 | |
| ERVKGRDKHINNLKK | 446 | Q6P2H3 | |
| EAENIRGKDKHQARI | 311 | Q12860 | |
| TDGNKHRAKVDKRKQ | 321 | O00458 | |
| SKQRVKKDVDKGTRH | 251 | Q8TBB5 | |
| RRIKEIVKKHSQFIG | 201 | P07900 | |
| IKEGRLKETQKHRVD | 256 | P24462 | |
| LRKVARINGHKEAKN | 296 | Q9NSA0 | |
| TTKINRHDKINGKRK | 181 | E9PJ23 | |
| RHDKINGKRKTARKQ | 186 | E9PJ23 | |
| NRLNKVIKSVGKIEH | 1056 | Q16531 | |
| LRTFHKETGRKDQKQ | 166 | Q8NG08 | |
| KVTTKINRHDKINGK | 176 | F8W1W9 | |
| INRHDKINGKRKTAR | 181 | F8W1W9 | |
| HKEKRKILTTEGRNA | 1006 | Q08211 | |
| KDNLHQVSKRLRGEV | 86 | Q9UKD2 | |
| IFDKLHKVGIKTRRQ | 321 | Q96RD6 | |
| QLKDHIDRSRKKRGE | 301 | Q8N4C8 | |
| KNGRPLKEEKNRVHI | 176 | P43121 | |
| VTTKVNRHDKINGKR | 126 | E9PJI5 | |
| NRHDKINGKRKTAKE | 131 | E9PJI5 | |
| VTTKVNRHDKINGKR | 126 | P0DM63 | |
| NRHDKINGKRKTAKE | 131 | P0DM63 | |
| EAKNRDHRKIGKEQE | 396 | A2RTX5 | |
| QTAHNKEKRRKDDGI | 241 | Q9BQF6 | |
| KVKEKFQQLRHRIQD | 46 | Q12981 | |
| GKHRKKNSVFERLQI | 226 | Q9NUP7 | |
| RRKDKLEHSQQKCIV | 56 | Q8N7P1 | |
| RQKGEHSVRAAGKEK | 1796 | O95425 | |
| GRNSKIKQVDSVLKH | 1886 | Q8WXH0 | |
| KNRRQKAHVTDPKAD | 6681 | Q8WXH0 | |
| LKELRRVAHINGKKN | 296 | Q8N4F4 | |
| ARKGALRQKNVHEVK | 21 | P17252 | |
| GHERKLVTKLQNSER | 61 | O60356 | |
| VTTKVNRHDKINGKR | 126 | E9PKD4 | |
| NRHDKINGKRKTAKE | 131 | E9PKD4 | |
| QRAFGAKLKEIEKQH | 866 | Q8IVG5 | |
| RKGLNSIVHKAKIEQ | 1481 | Q8IVG5 | |
| GKRLERLVHKGKIDQ | 1486 | Q5K651 | |
| QHKQKTSRKPREERD | 681 | O75376 | |
| ERLKHAQKRRAQQVK | 21 | Q96I34 | |
| QQQKRGRREHKALIK | 346 | Q5VSL9 | |
| IEDAKAHRRNKKDVN | 476 | Q9Y2E8 | |
| ERKRKENSGAQLHVT | 46 | Q15054 | |
| GGKNVHELEKVRKQL | 1521 | P13533 | |
| TQKQKLARHVRDKEE | 591 | Q5VT25 | |
| KDEIIRVGDNKKIHQ | 1256 | Q5VT25 | |
| KLKHARNQVDVEIKR | 71 | Q9H0H5 | |
| GLRKQHQSDVEALKR | 2186 | Q9H2D6 | |
| LSEEEQPKKKHRRNR | 126 | Q9Y2V3 | |
| RVKKHGIKEVSGERK | 61 | Q8IY92 | |
| LQEHGSRKQKIKEAS | 31 | Q5SY13 | |
| RVLGQAKQEVEHKKK | 1241 | P35749 | |
| LKRFEHVGKQRRKIN | 596 | Q70EK9 | |
| QLDQGNKDVRHKGKR | 371 | Q8N0X7 | |
| HGKKGRAKQNLERVC | 846 | O95625 | |
| RKRNPSRKKQHICDE | 241 | P17028 | |
| VDQRHRASQLRKQKK | 51 | Q2NL82 | |
| RNPKRITTRHNKEEK | 751 | Q5TAP6 | |
| RKEQEVQRSKKQAHR | 286 | Q8N443 | |
| KRAHTEEPQAKKVRA | 811 | Q9BQ52 | |
| KRRHGEVQGNLKQIK | 411 | Q8NDV3 | |
| THEGKRQQKRAEVLE | 491 | Q8NDV3 | |
| KQEQREAHRKKSLEG | 336 | Q9NQ55 | |
| FQRRVDGKKNTKKRH | 366 | Q8TEJ3 | |
| LRAVKKRIVGNKNFH | 51 | O60784 | |
| TRNAEIGNKDIKFKH | 741 | Q8TCJ2 | |
| GRFRVTKVEHKSNQK | 226 | Q8IUW5 | |
| KIFGATKHRESIRKQ | 386 | Q9BX26 | |
| TVQERKQKDRKALHE | 216 | Q9NPL8 | |
| EGGVLKKVIRHKRQS | 21 | P24821 | |
| KKVIRHKRQSGVNAT | 26 | P24821 | |
| ERGKNHKENVAKRIS | 31 | O75554 | |
| KGSQTVRKHREQKER | 446 | Q92620 | |
| VERHRKKKINAGINR | 26 | Q68DE3 | |
| KEKVQLIEDRHRKNN | 1246 | P11277 | |
| QASNHSEKQKIRKPR | 346 | Q9BZ95 | |
| IENVKRGQHKKTLER | 456 | A7E2V4 | |
| IIAHNRGEERNKKID | 576 | Q96Q05 | |
| HIRLKKGRDQTHEAK | 106 | Q13769 | |
| VKHRKQQVLETVAGK | 336 | P17948 | |
| VRKNRKIHKDAESAQ | 691 | Q8NFY4 | |
| NKKEKATGREVTHIQ | 801 | P08575 | |
| KKHGRLIATINIQEK | 76 | A0A0B4J266 | |
| KVLEEQIGVHRKSRK | 3526 | O14686 | |
| LEKSRVLKQHVGERN | 186 | B0I1T2 | |
| KARRERIHTKKGNFN | 316 | Q8NEV4 | |
| EKRNKHGVSRKKIAQ | 516 | Q92802 | |
| KELARRNIHGVSKEK | 551 | Q86UW6 | |
| DLHQKKVGRAKRESR | 1261 | B2RTY4 |